<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
	<head>
		<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
		<meta http-equiv="Content-Style-Type" content="text/css" />
		<meta name="generator" content="MediaWiki 1.15alpha" />
		<meta name="keywords" content="Selective serotonin reuptake inhibitor,Articles with unsourced statements since March 2009,Articles with unsourced statements since April 2008,Articles with unsourced statements since August 2007,Articles with unsourced statements since March 2008,Articles with unsourced statements since February 2008,Antidepressants,Receptor agonists and antagonists,5-HT,5-HT2A receptor,5-HT3 antagonist" />
		<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Selective_serotonin_reuptake_inhibitor&amp;action=edit" />
		<link rel="edit" title="Edit this page" href="/w/index.php?title=Selective_serotonin_reuptake_inhibitor&amp;action=edit" />
		<link rel="apple-touch-icon" href="http://en.wikipedia.org/apple-touch-icon.png" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
		<link rel="copyright" href="http://www.gnu.org/copyleft/fdl.html" />
		<link rel="alternate" type="application/rss+xml" title="Wikipedia RSS Feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=rss" />
		<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom Feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
		<title>Selective serotonin reuptake inhibitor - Wikipedia, the free encyclopedia</title>
		<link rel="stylesheet" href="/skins-1.5/common/shared.css?207xx" type="text/css" media="screen" />
		<link rel="stylesheet" href="/skins-1.5/common/commonPrint.css?207xx" type="text/css" media="print" />
		<link rel="stylesheet" href="/skins-1.5/monobook/main.css?207xx" type="text/css" media="screen" />
		<link rel="stylesheet" href="/skins-1.5/chick/main.css?207xx" type="text/css" media="handheld" />
		<!--[if lt IE 5.5000]><link rel="stylesheet" href="/skins-1.5/monobook/IE50Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 5.5000]><link rel="stylesheet" href="/skins-1.5/monobook/IE55Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 6]><link rel="stylesheet" href="/skins-1.5/monobook/IE60Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 7]><link rel="stylesheet" href="/skins-1.5/monobook/IE70Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Common.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Print.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" media="print" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Handheld.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" media="handheld" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Monobook.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" />
		<link rel="stylesheet" href="/w/index.php?title=-&amp;action=raw&amp;maxage=2678400&amp;gen=css" type="text/css" />
		<!--[if lt IE 7]><script type="text/javascript" src="/skins-1.5/common/IEFixes.js?207xx"></script>
		<meta http-equiv="imagetoolbar" content="no" /><![endif]-->

		<script type= "text/javascript">/*<![CDATA[*/
		var skin = "monobook";
		var stylepath = "/skins-1.5";
		var wgArticlePath = "/wiki/$1";
		var wgScriptPath = "/w";
		var wgScript = "/w/index.php";
		var wgVariantArticlePath = false;
		var wgActionPaths = {};
		var wgServer = "http://en.wikipedia.org";
		var wgCanonicalNamespace = "";
		var wgCanonicalSpecialPageName = false;
		var wgNamespaceNumber = 0;
		var wgPageName = "Selective_serotonin_reuptake_inhibitor";
		var wgTitle = "Selective serotonin reuptake inhibitor";
		var wgAction = "view";
		var wgArticleId = "29581";
		var wgIsArticle = true;
		var wgUserName = null;
		var wgUserGroups = null;
		var wgUserLanguage = "en";
		var wgContentLanguage = "en";
		var wgBreakFrames = false;
		var wgCurRevisionId = 281579522;
		var wgVersion = "1.15alpha";
		var wgEnableAPI = true;
		var wgEnableWriteAPI = true;
		var wgSeparatorTransformTable = ["", ""];
		var wgDigitTransformTable = ["", ""];
		var wgMWSuggestTemplate = "http://en.wikipedia.org/w/api.php?action=opensearch\x26search={searchTerms}\x26namespace={namespaces}\x26suggest";
		var wgDBname = "enwiki";
		var wgSearchNamespaces = [0];
		var wgMWSuggestMessages = ["with suggestions", "no suggestions"];
		var wgRestrictionEdit = [];
		var wgRestrictionMove = [];
		/*]]>*/</script>

		<script type="text/javascript" src="/skins-1.5/common/wikibits.js?207xx"><!-- wikibits js --></script>
		<!-- Head Scripts -->
		<script type="text/javascript" src="/skins-1.5/common/ajax.js?207xx"></script>
		<script type="text/javascript" src="/skins-1.5/common/mwsuggest.js?207xx"></script>
<script type="text/javascript">/*<![CDATA[*/
var wgNotice='';var wgNoticeLocal='';
/*]]>*/</script>		<script type="text/javascript" src="http://upload.wikimedia.org/centralnotice/wikipedia/en/centralnotice.js?207xx"></script>
		<script type="text/javascript" src="/w/index.php?title=-&amp;action=raw&amp;gen=js&amp;useskin=monobook"><!-- site js --></script>
	</head>
<body class="mediawiki ltr ns-0 ns-subject page-Selective_serotonin_reuptake_inhibitor skin-monobook">
	<div id="globalWrapper">
		<div id="column-content">
	<div id="content">
		<a name="top" id="top"></a>
		<div id="siteNotice"><script type='text/javascript'>if (wgNotice != '') document.writeln(wgNotice);</script></div>		<h1 id="firstHeading" class="firstHeading">Selective serotonin reuptake inhibitor</h1>
		<div id="bodyContent">
			<h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
			<div id="contentSub"></div>
									<div id="jump-to-nav">Jump to: <a href="#column-one">navigation</a>, <a href="#searchInput">search</a></div>			<!-- start content -->
			<div class="dablink">"SSRI" redirects here; for other uses, see <a href="/wiki/SSRI_(disambiguation)" title="SSRI (disambiguation)">SSRI (disambiguation)</a>.</div>
<div class="thumb tright">
<div class="thumbinner" style="width:182px;"><a href="/wiki/File:Serotonin_(5-HT).svg" class="image" title="Serotonin"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/0/04/Serotonin_%285-HT%29.svg/180px-Serotonin_%285-HT%29.svg.png" width="180" height="131" border="0" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Serotonin_(5-HT).svg" class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
<a href="/wiki/Serotonin" title="Serotonin">Serotonin</a></div>
</div>
</div>
<p><b>Selective serotonin reuptake inhibitors</b> or <b>serotonin-specific reuptake inhibitor</b><sup id="cite_ref-BARLOW_0-0" class="reference"><a href="#cite_note-BARLOW-0" title=""><span>[</span>1<span>]</span></a></sup> (<b>SSRIs</b>) are a class of compounds typically used as <a href="/wiki/Antidepressants" title="Antidepressants" class="mw-redirect">antidepressants</a> in the treatment of <a href="/wiki/Clinical_depression" title="Clinical depression" class="mw-redirect">depression</a>, <a href="/wiki/Anxiety_disorder" title="Anxiety disorder">anxiety disorders</a>, and some <a href="/wiki/Personality_disorder" title="Personality disorder">personality disorders</a>. They are also typically effective and used in treating <a href="/wiki/Premature_ejaculation" title="Premature ejaculation">premature ejaculation</a> problems as well as some cases of insomnia<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since March 2009" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup>.</p>
<p>SSRIs increase the <a href="/wiki/Extracellular" title="Extracellular">extracellular</a> level of the <a href="/wiki/Neurotransmitter" title="Neurotransmitter">neurotransmitter</a> <a href="/wiki/Serotonin" title="Serotonin">serotonin</a> by inhibiting its <a href="/wiki/Reuptake" title="Reuptake">reuptake</a> into the <a href="/wiki/Presynaptic_cell" title="Presynaptic cell" class="mw-redirect">presynaptic cell</a>, increasing the level of <a href="/wiki/Serotonin" title="Serotonin">serotonin</a> available to bind to the postsynaptic receptor. They have varying degrees of selectivity for the other <a href="/wiki/Monoamine_transporter" title="Monoamine transporter">monoamine transporters</a>, with pure <b>SSRIs</b> having only weak affinity for the <a href="/wiki/Noradrenaline_transporter" title="Noradrenaline transporter" class="mw-redirect">noradrenaline</a> and <a href="/wiki/Dopamine_transporter" title="Dopamine transporter">dopamine transporter</a>.</p>
<p>The first class of <a href="/wiki/Psychotropic_drugs" title="Psychotropic drugs" class="mw-redirect">psychotropic drugs</a> to be <a href="/wiki/Drug_design#Rational_drug_design" title="Drug design">rationally designed</a>, SSRIs are the most widely prescribed antidepressants in many countries.<sup id="cite_ref-1" class="reference"><a href="#cite_note-1" title=""><span>[</span>2<span>]</span></a></sup></p>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a href="#List_of_SSRIs"><span class="tocnumber">1</span> <span class="toctext">List of SSRIs</span></a></li>
<li class="toclevel-1"><a href="#Related_antidepressants"><span class="tocnumber">2</span> <span class="toctext">Related antidepressants</span></a></li>
<li class="toclevel-1"><a href="#Medical_indications"><span class="tocnumber">3</span> <span class="toctext">Medical indications</span></a></li>
<li class="toclevel-1"><a href="#Contraindications_and_drug_interaction"><span class="tocnumber">4</span> <span class="toctext">Contraindications and drug interaction</span></a></li>
<li class="toclevel-1"><a href="#Mode_of_action"><span class="tocnumber">5</span> <span class="toctext">Mode of action</span></a>
<ul>
<li class="toclevel-2"><a href="#Basic_understanding"><span class="tocnumber">5.1</span> <span class="toctext">Basic understanding</span></a></li>
<li class="toclevel-2"><a href="#Pharmacodynamics"><span class="tocnumber">5.2</span> <span class="toctext">Pharmacodynamics</span></a></li>
<li class="toclevel-2"><a href="#Pharmacogenetics"><span class="tocnumber">5.3</span> <span class="toctext">Pharmacogenetics</span></a></li>
<li class="toclevel-2"><a href="#Neuroprotection"><span class="tocnumber">5.4</span> <span class="toctext">Neuroprotection</span></a></li>
<li class="toclevel-2"><a href="#Anti-inflammatory_and_immunomodulation"><span class="tocnumber">5.5</span> <span class="toctext">Anti-inflammatory and immunomodulation</span></a></li>
<li class="toclevel-2"><a href="#SSRIs_versus_TCAs"><span class="tocnumber">5.6</span> <span class="toctext">SSRIs versus TCAs</span></a></li>
<li class="toclevel-2"><a href="#SSRIs_versus_5-HT-Prodrugs"><span class="tocnumber">5.7</span> <span class="toctext">SSRIs versus 5-HT-Prodrugs</span></a>
<ul>
<li class="toclevel-3"><a href="#SSRIs_together_with_5-HT-Prodrugs"><span class="tocnumber">5.7.1</span> <span class="toctext">SSRIs together with 5-HT-Prodrugs</span></a></li>
</ul>
</li>
</ul>
</li>
<li class="toclevel-1"><a href="#Adverse_effects"><span class="tocnumber">6</span> <span class="toctext">Adverse effects</span></a>
<ul>
<li class="toclevel-2"><a href="#General_side_effects"><span class="tocnumber">6.1</span> <span class="toctext">General side effects</span></a></li>
<li class="toclevel-2"><a href="#Sexual_side_effects"><span class="tocnumber">6.2</span> <span class="toctext">Sexual side effects</span></a></li>
<li class="toclevel-2"><a href="#Cardiovascular_side_effects"><span class="tocnumber">6.3</span> <span class="toctext">Cardiovascular side effects</span></a></li>
<li class="toclevel-2"><a href="#Discontinuation_syndrome"><span class="tocnumber">6.4</span> <span class="toctext">Discontinuation syndrome</span></a></li>
<li class="toclevel-2"><a href="#Suicidality_and_aggression"><span class="tocnumber">6.5</span> <span class="toctext">Suicidality and aggression</span></a></li>
<li class="toclevel-2"><a href="#SSRIs_and_pregnancy"><span class="tocnumber">6.6</span> <span class="toctext">SSRIs and pregnancy</span></a>
<ul>
<li class="toclevel-3"><a href="#Neonatal_abstinence_syndrome"><span class="tocnumber">6.6.1</span> <span class="toctext">Neonatal abstinence syndrome</span></a></li>
<li class="toclevel-3"><a href="#Permanent_neuropsychological_changes"><span class="tocnumber">6.6.2</span> <span class="toctext">Permanent neuropsychological changes</span></a></li>
<li class="toclevel-3"><a href="#Persistent_pulmonary_hypertension"><span class="tocnumber">6.6.3</span> <span class="toctext">Persistent pulmonary hypertension</span></a></li>
</ul>
</li>
<li class="toclevel-2"><a href="#Interaction_with_carbohydrate_metabolism"><span class="tocnumber">6.7</span> <span class="toctext">Interaction with carbohydrate metabolism</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Overdose"><span class="tocnumber">7</span> <span class="toctext">Overdose</span></a></li>
<li class="toclevel-1"><a href="#Criticism"><span class="tocnumber">8</span> <span class="toctext">Criticism</span></a></li>
<li class="toclevel-1"><a href="#Lawsuits"><span class="tocnumber">9</span> <span class="toctext">Lawsuits</span></a></li>
<li class="toclevel-1"><a href="#See_also"><span class="tocnumber">10</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1"><a href="#References_and_notes"><span class="tocnumber">11</span> <span class="toctext">References and notes</span></a></li>
<li class="toclevel-1"><a href="#External_links"><span class="tocnumber">12</span> <span class="toctext">External links</span></a></li>
</ul>
</td>
</tr>
</table>
<script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script>
<p><a name="List_of_SSRIs" id="List_of_SSRIs"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Selective_serotonin_reuptake_inhibitor&amp;action=edit&amp;section=1" title="Edit section: List of SSRIs">edit</a>]</span> <span class="mw-headline">List of SSRIs</span></h2>
<p>Drugs in this class include (trade names in parentheses):</p>
<ul>
<li><a href="/wiki/Citalopram" title="Citalopram">citalopram</a> (Celexa, Cipramil, Dalsan, Recital, Emocal, Sepram, Seropram, Citox)</li>
<li><a href="/wiki/Dapoxetine" title="Dapoxetine">dapoxetine</a> (no trade name yet; not yet approved by the FDA)</li>
<li><a href="/wiki/Escitalopram" title="Escitalopram">escitalopram</a> (Lexapro, Cipralex, Esertia)</li>
<li><a href="/wiki/Fluoxetine" title="Fluoxetine">fluoxetine</a> (Prozac, Fontex, Seromex, Seronil, Sarafem, Fluctin (EUR), Fluox (NZ), Depress (UZB), Lovan (AUS))</li>
<li><a href="/wiki/Fluvoxamine" title="Fluvoxamine">fluvoxamine</a> (Luvox, Fevarin, Faverin, Dumyrox, Favoxil, Movox)</li>
<li><a href="/wiki/Paroxetine" title="Paroxetine">paroxetine</a> (Paxil, Seroxat, Sereupin, Aropax, Deroxat, Rexetin, Xetanor, Paroxat)</li>
<li><a href="/wiki/Sertraline" title="Sertraline">sertraline</a> (Zoloft, Lustral, Serlain)</li>
<li><a href="/wiki/Zimelidine" title="Zimelidine">zimelidine</a> (Zelmid, Normud)</li>
</ul>
<p><a name="Related_antidepressants" id="Related_antidepressants"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Selective_serotonin_reuptake_inhibitor&amp;action=edit&amp;section=2" title="Edit section: Related antidepressants">edit</a>]</span> <span class="mw-headline">Related antidepressants</span></h2>
<p>SSRIs form a subclass of <a href="/wiki/Serotonin_uptake_inhibitor" title="Serotonin uptake inhibitor">serotonin uptake inhibitors</a>, which includes other <a href="/wiki/Non-selective" title="Non-selective" class="mw-redirect">non-selective</a> inhibitors as well. <a href="/wiki/Serotonin-norepinephrine_reuptake_inhibitor" title="Serotonin-norepinephrine reuptake inhibitor">Serotonin-norepinephrine reuptake inhibitor</a>, <a href="/wiki/Serotonin-noradrenaline-dopamine_reuptake_inhibitor" title="Serotonin-noradrenaline-dopamine reuptake inhibitor">serotonin-noradrenaline-dopamine reuptake inhibitors</a> and <a href="/wiki/Selective_serotonin_reuptake_enhancer" title="Selective serotonin reuptake enhancer">selective serotonin reuptake enhancers</a> are also <a href="/wiki/Serotonergic" title="Serotonergic">serotonergic</a> antidepressants.</p>
<p><a name="Medical_indications" id="Medical_indications"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Selective_serotonin_reuptake_inhibitor&amp;action=edit&amp;section=3" title="Edit section: Medical indications">edit</a>]</span> <span class="mw-headline">Medical indications</span></h2>
<p>The main indication for SSRIs is <a href="/wiki/Clinical_depression" title="Clinical depression" class="mw-redirect">clinical depression</a>. SSRIs are frequently prescribed for <a href="/wiki/Anxiety_disorder" title="Anxiety disorder">anxiety disorders</a> like <a href="/wiki/Social_anxiety" title="Social anxiety">social anxiety</a>, <a href="/wiki/Panic_disorder" title="Panic disorder">panic disorders</a>, <a href="/wiki/Obsessive-compulsive_disorder" title="Obsessive-compulsive disorder">obsessive-compulsive disorder</a> (OCD), <a href="/wiki/Eating_disorder" title="Eating disorder">eating disorders</a>, <a href="/wiki/Chronic_pain" title="Chronic pain">chronic pain</a>, and occasionally for <a href="/wiki/Posttraumatic_stress_disorder" title="Posttraumatic stress disorder">Posttraumatic stress disorder</a> (PTSD). Though not specifically indicated by the manufacturers, they are sometimes prescribed to treat <a href="/wiki/Irritable_bowel_syndrome" title="Irritable bowel syndrome">irritable bowel syndrome</a> (IBS), <a href="/wiki/Lichen_simplex_chronicus" title="Lichen simplex chronicus">Lichen simplex chronicus</a>, and <a href="/wiki/Premature_ejaculation" title="Premature ejaculation">premature ejaculation</a>.</p>
<p>All SSRIs are approved in the US for use with <a href="/wiki/Psychiatric" title="Psychiatric" class="mw-redirect">psychiatric</a> disorders as outlined in the <a href="/wiki/Diagnostic_and_Statistical_Manual_of_Mental_Disorders" title="Diagnostic and Statistical Manual of Mental Disorders">Diagnostic and Statistical Manual of Mental Disorders</a> (DSM IV).</p>
<p>The uses for which SSRIs are approved vary by country and is determined by the overseeing medical branch of government in charge of regulating drugs. In the United States, the <a href="/wiki/U.S._Food_and_Drug_Administration" title="U.S. Food and Drug Administration">Food and Drug Administration</a> (FDA) makes these approvals after trials have been submitted by <a href="/wiki/Pharmaceutical_company" title="Pharmaceutical company" class="mw-redirect">pharmaceutical companies</a>. In Europe, drugs can be approved either by the <a href="/wiki/European_Medicines_Agency" title="European Medicines Agency">European Medicines Agency</a> for human consumption throughout the <a href="/wiki/European_Union" title="European Union">European Union</a> or by the regulatory agencies of individual countries for use within those countries.<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since April 2008" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup>. In Canada the drug approval process is carried out by <a href="/wiki/Health_Canada" title="Health Canada">Health Canada</a>.</p>
<p>A general disadvantage of SSRIs in treating premature ejaculation is that they require continuous daily treatment to delay ejaculation significantly.<sup id="cite_ref-pmid17983899_2-0" class="reference"><a href="#cite_note-pmid17983899-2" title=""><span>[</span>3<span>]</span></a></sup> For the occasional "on-demand", a few hours before coitus, treatment, <a href="/wiki/Clomipramine" title="Clomipramine">clomipramine</a> gave better results than paroxetine in one study,<sup id="cite_ref-pmid15363569_3-0" class="reference"><a href="#cite_note-pmid15363569-3" title=""><span>[</span>4<span>]</span></a></sup> while in another study both sertraline and clomipramine were indistinguishable from the pause–squeeze technique and inferior to paroxetine.<sup id="cite_ref-pmid11313839_4-0" class="reference"><a href="#cite_note-pmid11313839-4" title=""><span>[</span>5<span>]</span></a></sup> The most recent research, conducted in 2007, suggests that on-demand treatment with <a href="/wiki/Sildenafil" title="Sildenafil">sildenafil</a> (Viagra) offers a dramatic improvement in ejaculation delay and sexual satisfaction as compared with daily paroxetine,<sup id="cite_ref-pmid17470165_5-0" class="reference"><a href="#cite_note-pmid17470165-5" title=""><span>[</span>6<span>]</span></a></sup> with on-demand sertraline, paroxetine or clomipramine,<sup id="cite_ref-pmid11313839_4-1" class="reference"><a href="#cite_note-pmid11313839-4" title=""><span>[</span>5<span>]</span></a></sup> and with the pause–squeeze technique.<sup id="cite_ref-pmid11313839_4-2" class="reference"><a href="#cite_note-pmid11313839-4" title=""><span>[</span>5<span>]</span></a></sup><sup id="cite_ref-pmid17470165_5-1" class="reference"><a href="#cite_note-pmid17470165-5" title=""><span>[</span>6<span>]</span></a></sup></p>
<p><a name="Contraindications_and_drug_interaction" id="Contraindications_and_drug_interaction"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Selective_serotonin_reuptake_inhibitor&amp;action=edit&amp;section=4" title="Edit section: Contraindications and drug interaction">edit</a>]</span> <span class="mw-headline">Contraindications and drug interaction</span></h2>
<p>One major contraindication of SSRIs is the concomitant use of MAOIs (<a href="/wiki/Monoamine_oxidase_inhibitor" title="Monoamine oxidase inhibitor">monoamine oxidase inhibitors</a>). This is likely to cause severe <a href="/wiki/Serotonin_syndrome" title="Serotonin syndrome">serotonin syndrome</a>.</p>
<p>People taking SSRIs should also avoid taking <a href="/wiki/Pimozide" title="Pimozide">pimozide</a> (an <a href="/wiki/Antipsychotic" title="Antipsychotic">antipsychotic</a> diphenylbutylpiperidine derivative). The atypical <a href="/wiki/Opioid" title="Opioid">opioid analgesic</a> <a href="/wiki/Tramadol" title="Tramadol">tramadol</a> hydrochloride (or Ultram, Ultracet) can, in rare cases, produce <a href="/wiki/Seizure_(medicine)" title="Seizure (medicine)" class="mw-redirect">seizures</a> when taken in conjunction with an SSRI or <a href="/wiki/Tricyclic_antidepressant" title="Tricyclic antidepressant">tricyclic antidepressant</a>. <a href="/wiki/Liver" title="Liver">Liver</a> impairment is another contraindication for medications of this type.</p>
<p>SSRIs may increase blood levels and risk of toxicities of certain medications:</p>
<ol>
<li>highly protein-bound medications like <a href="/wiki/Warfarin" title="Warfarin">warfarin</a> (coumadin) and <a href="/wiki/Digoxin" title="Digoxin">digoxin</a></li>
<li><a href="/wiki/Antiarrhythmic_agent" title="Antiarrhythmic agent">antiarrhythmic agents</a> like <a href="/wiki/Propafenone" title="Propafenone">propafenone</a> (Rythmol) or <a href="/wiki/Flecainide" title="Flecainide">flecainide</a> (Tambocor)</li>
<li><a href="/wiki/Beta_blocker" title="Beta blocker">beta blockers</a> like <a href="/wiki/Metoprolol" title="Metoprolol">metoprolol</a> (Toprol xl) or <a href="/wiki/Propranolol" title="Propranolol">propranolol</a> (Inderal)</li>
<li><a href="/wiki/Tricyclic_antidepressant" title="Tricyclic antidepressant">tricyclic antidepressants</a> like <a href="/wiki/Amitriptyline" title="Amitriptyline">amitriptyline</a> (Elavil) (may increase risk of serotonin syndrome)</li>
<li><a href="/wiki/Benzodiazepine" title="Benzodiazepine">benzodiazepines</a> like <a href="/wiki/Alprazolam" title="Alprazolam">alprazolam</a> (Xanax) or <a href="/wiki/Diazepam" title="Diazepam">diazepam</a> (Valium)</li>
<li><a href="/wiki/Carbamazepine" title="Carbamazepine">carbamazepine</a> (Tegretol)</li>
<li><a href="/wiki/Cisapride" title="Cisapride">cisapride</a> (Propulsid)</li>
<li><a href="/wiki/Clozapine" title="Clozapine">clozapine</a> (Clozaril)</li>
<li><a href="/wiki/Ciclosporin" title="Ciclosporin">ciclosporin</a> (Neoral)</li>
<li><a href="/wiki/Haloperidol" title="Haloperidol">haloperidol</a> (Haldol)</li>
<li><a href="/wiki/Phenytoin" title="Phenytoin">phenytoin</a> (Dilantin)</li>
<li><a href="/wiki/Pimozide" title="Pimozide">pimozide</a> (Orap)</li>
<li><a href="/wiki/Theophylline" title="Theophylline">theophylline</a> (Theo-dur)</li>
</ol>
<p>Certain drugs may increase toxicities of SSRIs:</p>
<ol>
<li><a href="/wiki/Alcohol" title="Alcohol">alcohol</a> and other CNS depressants</li>
<li><a href="/wiki/Diuretic" title="Diuretic">diuretics</a> (water pills)</li>
<li><a href="/wiki/MAOIs" title="MAOIs" class="mw-redirect">MAOIs</a></li>
<li><a href="/wiki/Sympathomimetic_drug" title="Sympathomimetic drug">sympathomimetic drugs</a> like <a href="/wiki/Pseudoephedrine" title="Pseudoephedrine">pseudoephedrine</a> (Sudafed)</li>
<li><a href="/wiki/Lithium" title="Lithium">lithium</a></li>
<li><a href="/wiki/Sibutramine" title="Sibutramine">sibutramine</a> (Meridia)</li>
<li><a href="/wiki/MDMA" title="MDMA">MDMA</a> (ecstasy)</li>
<li><a href="/wiki/Zolpidem" title="Zolpidem">zolpidem</a> (ambien)<sup id="cite_ref-6" class="reference"><a href="#cite_note-6" title=""><span>[</span>7<span>]</span></a></sup></li>
<li><a href="/wiki/Dextromethorphan" title="Dextromethorphan">Dextromethorphan</a></li>
<li><a href="/wiki/Tramadol" title="Tramadol">tramadol</a> (synergistic serotoninergic effect said to increase risk of seizure)</li>
</ol>
<p><a name="Mode_of_action" id="Mode_of_action"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Selective_serotonin_reuptake_inhibitor&amp;action=edit&amp;section=5" title="Edit section: Mode of action">edit</a>]</span> <span class="mw-headline">Mode of action</span></h2>
<p>SSRIs act by inhibiting the reuptake of <a href="/wiki/Serotonin" title="Serotonin">serotonin</a> after being released in synapses. How much an individual will respond to this, however, also depends on genetics. In addition, several other mechanisms are suggested for the desired effect, e.g. neuroprotection and anti-inflammatory and immunomodulatory factors. Taken together, SSRI has several advantages compared with <a href="/wiki/Tricyclic_antidepressants" title="Tricyclic antidepressants" class="mw-redirect">tricyclic antidepressants</a> (TCA)s and 5-HT-<a href="/wiki/Prodrugs" title="Prodrugs" class="mw-redirect">prodrugs</a>. However, the latter might be required in addition to SSRIs in certain situations.</p>
<p><a name="Basic_understanding" id="Basic_understanding"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Selective_serotonin_reuptake_inhibitor&amp;action=edit&amp;section=6" title="Edit section: Basic understanding">edit</a>]</span> <span class="mw-headline">Basic understanding</span></h3>
<div class="rellink">Further information: <a href="/wiki/Chemical_synapse" title="Chemical synapse">Chemical synapse</a></div>
<p>In the <a href="/wiki/Brain" title="Brain">brain</a>, messages are passed between two <a href="/wiki/Neuron" title="Neuron">nerve cells</a> via a <a href="/wiki/Synapse" title="Synapse" class="mw-redirect">synapse</a>, a small gap between the cells. The (presynaptic) cell that sends the information releases <a href="/wiki/Neurotransmitter" title="Neurotransmitter">neurotransmitters</a> (of which serotonin is one) into that gap. The neurotransmitters are then recognized by <a href="/wiki/Receptor_(biochemistry)" title="Receptor (biochemistry)">receptors</a> on the surface of the recipient (postsynaptic) cell, which upon this stimulation, in turn, relays the signal. About 10% of the neurotransmitters are lost in this process; the other 90% are released from the receptors and taken up again by <a href="/wiki/Monoamine_transporter" title="Monoamine transporter">monoamine transporters</a> into the sending (presynaptic) cell (a process called <i>reuptake</i>).</p>
<p>Some theories link <a href="/wiki/Clinical_depression" title="Clinical depression" class="mw-redirect">depression</a> to a lack of stimulation of the recipient neuron at a synapse<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since August 2007" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup>. To stimulate the recipient cell, SSRIs inhibit the reuptake of serotonin. As a result, the serotonin stays in the synaptic gap longer than it normally would, and may be recognized again (and again) by the receptors of the recipient cell, stimulating it.</p>
<p><a name="Pharmacodynamics" id="Pharmacodynamics"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Selective_serotonin_reuptake_inhibitor&amp;action=edit&amp;section=7" title="Edit section: Pharmacodynamics">edit</a>]</span> <span class="mw-headline">Pharmacodynamics</span></h3>
<p>SSRIs inhibit the reuptake of the neurotransmitter <a href="/wiki/Serotonin" title="Serotonin">serotonin</a> (5-hydroxytryptamine or 5-HT) into the presynaptic cell, increasing levels of 5-HT within the <a href="/wiki/Synaptic_cleft" title="Synaptic cleft" class="mw-redirect">synaptic cleft</a>.</p>
<p>But there is one counteracting effect: high serotonin levels will not only activate the <a href="/wiki/Postsynaptic" title="Postsynaptic" class="mw-redirect">postsynaptic</a> receptors, but also flood presynaptic <a href="/wiki/Autoreceptor" title="Autoreceptor">autoreceptors</a>, that serve as a feedback sensor for the cell. Activation of the autoreceptors (by <a href="/wiki/Agonist" title="Agonist">agonists</a> like serotonin) triggers a throttling of serotonin production. The resulting serotonin deficiency persists for some time, as the transporter inhibition occurs downstream to the cause of the deficiency, and is therefore not able to counterbalance the serotonin deficiency. The body adapts gradually to this situation by lowering (<a href="/wiki/Downregulation" title="Downregulation" class="mw-redirect">downregulating</a>) the sensitivity of the autoreceptors<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since March 2008" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup>.</p>
<p>Of greater importance is another adaptive process: the downregulation of postsynaptic <a href="/wiki/5-HT2A_receptor" title="5-HT2A receptor">serotonin 5-HT<sub>2A</sub> receptors</a>. After the use of an SSRI, since there is more serotonin available, the response is to lower (to normal levels or less) the number of postsynaptic receptors over time, and in the long run, this modifies the serotonin/receptor ratio. Since a larger percentage of available receptors become activated by serotonin, transmission is enhanced or restored<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since March 2008" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup>.</p>
<p>These (slowly proceeding) neurophysiological adaptions of the brain tissue are the reason why usually several weeks of continuous SSRI use are necessary for the antidepressant effect to become fully manifested<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since March 2008" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup>, and why increased anxiety is a common side effect in the first few days or weeks of use.</p>
<p><a name="Pharmacogenetics" id="Pharmacogenetics"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Selective_serotonin_reuptake_inhibitor&amp;action=edit&amp;section=8" title="Edit section: Pharmacogenetics">edit</a>]</span> <span class="mw-headline">Pharmacogenetics</span></h3>
<div class="rellink">Further information: <a href="/wiki/Pharmacogenetics" title="Pharmacogenetics">Pharmacogenetics</a></div>
<p>Large bodies of research are devoted to using <a href="/wiki/Genetic_marker" title="Genetic marker">genetic markers</a> to predict whether patients will respond to SSRIs or have side effects which will cause their <a href="/wiki/Discontinuation" title="Discontinuation">discontinuation</a>, although these tests are not yet ready for widespread clinical use.<sup id="cite_ref-7" class="reference"><a href="#cite_note-7" title=""><span>[</span>8<span>]</span></a></sup> <a href="/wiki/Single_nucleotide_polymorphisms" title="Single nucleotide polymorphisms" class="mw-redirect">Single nucleotide polymorphisms</a> of the <a href="/wiki/5-HT" title="5-HT" class="mw-redirect">5-HT(2A)</a> gene correlate with increased <a href="/wiki/Paroxetine" title="Paroxetine">paroxetine</a> discontinuation, but not <a href="/wiki/Mirtazapine" title="Mirtazapine">mirtazapine</a> (a non-SSRI antidepressant) discontinuation<sup id="cite_ref-8" class="reference"><a href="#cite_note-8" title=""><span>[</span>9<span>]</span></a></sup></p>
<p><a name="Neuroprotection" id="Neuroprotection"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Selective_serotonin_reuptake_inhibitor&amp;action=edit&amp;section=9" title="Edit section: Neuroprotection">edit</a>]</span> <span class="mw-headline">Neuroprotection</span></h3>
<p>Studies have suggested that SSRIs may promote the growth of new <a href="/wiki/Neural_pathway" title="Neural pathway">neural pathways</a> or <a href="/wiki/Neurogenesis" title="Neurogenesis">neurogenesis</a> in rats.<sup id="cite_ref-9" class="reference"><a href="#cite_note-9" title=""><span>[</span>10<span>]</span></a></sup> Also, SSRIs may protect against neurotoxicity caused by other compounds (for instance <a href="/wiki/MDMA" title="MDMA">MDMA</a> and <a href="/wiki/Fenfluramine" title="Fenfluramine">Fenfluramine</a>) as well as from depression itself. SSRIs have been found to induce programmed cell death in Burkitt lymphoma and the brain tumors neuroblastoma and glioma with minimal effect on normal tissue. <sup id="cite_ref-10" class="reference"><a href="#cite_note-10" title=""><span>[</span>11<span>]</span></a></sup>, <sup id="cite_ref-11" class="reference"><a href="#cite_note-11" title=""><span>[</span>12<span>]</span></a></sup></p>
<p><a name="Anti-inflammatory_and_immunomodulation" id="Anti-inflammatory_and_immunomodulation"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Selective_serotonin_reuptake_inhibitor&amp;action=edit&amp;section=10" title="Edit section: Anti-inflammatory and immunomodulation">edit</a>]</span> <span class="mw-headline">Anti-inflammatory and immunomodulation</span></h3>
<p>Recent studies show pro-inflammatory <a href="/wiki/Cytokine" title="Cytokine">cytokine</a> processes take place during <a href="/wiki/Clinical_depression" title="Clinical depression" class="mw-redirect">depression</a>, <a href="/wiki/Mania" title="Mania">mania</a> and <a href="/wiki/Bipolar_disorder" title="Bipolar disorder">bipolar disorder</a>, in addition to <a href="/wiki/Somatic" title="Somatic">somatic</a> disease (such as autoimmune <a href="/wiki/Hypersensitivity" title="Hypersensitivity">hypersensitivity</a>) and is possible that symptoms manifest in these psychiatric illnesses are being attenuated by pharmacological effect of antidepressants on the immune system.<sup id="cite_ref-12" class="reference"><a href="#cite_note-12" title=""><span>[</span>13<span>]</span></a></sup><sup id="cite_ref-13" class="reference"><a href="#cite_note-13" title=""><span>[</span>14<span>]</span></a></sup><sup id="cite_ref-14" class="reference"><a href="#cite_note-14" title=""><span>[</span>15<span>]</span></a></sup><sup id="cite_ref-15" class="reference"><a href="#cite_note-15" title=""><span>[</span>16<span>]</span></a></sup><sup id="cite_ref-16" class="reference"><a href="#cite_note-16" title=""><span>[</span>17<span>]</span></a></sup></p>
<p><a href="/wiki/SSRI" title="SSRI" class="mw-redirect">SSRIs</a> have been shown to be immunomodulatory and anti-inflammatory against pro-inflammatory <a href="/wiki/Cytokine" title="Cytokine">cytokine</a> processes, specifically on the regulation of <a href="/wiki/Interferon-gamma" title="Interferon-gamma">Interferon-gamma</a> (IFN-gamma) and <a href="/wiki/Interleukin-10" title="Interleukin-10" class="mw-redirect">Interleukin-10</a> (IL-10), as well as <a href="/wiki/TNF-alpha" title="TNF-alpha" class="mw-redirect">TNF-alpha</a> and <a href="/wiki/Interleukin-6" title="Interleukin-6" class="mw-redirect">Interleukin-6</a> (IL-6). Antidepressants have also been shown to suppress <a href="/wiki/T_helper_cell" title="T helper cell">TH1</a> upregulation.<sup id="cite_ref-17" class="reference"><a href="#cite_note-17" title=""><span>[</span>18<span>]</span></a></sup><sup id="cite_ref-18" class="reference"><a href="#cite_note-18" title=""><span>[</span>19<span>]</span></a></sup><sup id="cite_ref-19" class="reference"><a href="#cite_note-19" title=""><span>[</span>20<span>]</span></a></sup><sup id="cite_ref-20" class="reference"><a href="#cite_note-20" title=""><span>[</span>21<span>]</span></a></sup></p>
<p>Future serotonergic antidepressants may be made to specifically target the immune system by either blocking the actions of pro-inflammatory cytokines or increasing the production of anti-inflammatory cytokines.<sup id="cite_ref-21" class="reference"><a href="#cite_note-21" title=""><span>[</span>22<span>]</span></a></sup></p>
<p><a name="SSRIs_versus_TCAs" id="SSRIs_versus_TCAs"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Selective_serotonin_reuptake_inhibitor&amp;action=edit&amp;section=11" title="Edit section: SSRIs versus TCAs">edit</a>]</span> <span class="mw-headline">SSRIs versus TCAs</span></h3>
<p>SSRIs are described as '<a href="/wiki/Drug_selectivity" title="Drug selectivity" class="mw-redirect">selective</a>' because they affect only the reuptake pumps responsible for serotonin, as opposed to earlier antidepressants, which affect other monoamine neurotransmitters as well. Because of this, SSRIs lack some of the side effects of the more general drugs.</p>
<p>There appears to be no significant difference in effectiveness between SSRIs and <a href="/wiki/Tricyclic_antidepressant" title="Tricyclic antidepressant">tricyclic antidepressants</a>, which were the most commonly used class of antidepressants before the development of SSRIs.<sup id="cite_ref-22" class="reference"><a href="#cite_note-22" title=""><span>[</span>23<span>]</span></a></sup> However, SSRIs have the important advantage that their <a href="/wiki/Drug_overdose" title="Drug overdose">toxic dose</a> is high, and, therefore, they are much more difficult to use as a means to commit <a href="/wiki/Suicide" title="Suicide">suicide</a>. Further, they have fewer and milder <a href="/wiki/Adverse_drug_reaction" title="Adverse drug reaction">side effects</a>. Tricyclic antidepressant also have a higher risk of serious cardiovascular side effects which SSRIs lack.</p>
<p><a name="SSRIs_versus_5-HT-Prodrugs" id="SSRIs_versus_5-HT-Prodrugs"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Selective_serotonin_reuptake_inhibitor&amp;action=edit&amp;section=12" title="Edit section: SSRIs versus 5-HT-Prodrugs">edit</a>]</span> <span class="mw-headline">SSRIs versus 5-HT-Prodrugs</span></h3>
<div class="rellink">Further information: <a href="/wiki/Prodrugs" title="Prodrugs" class="mw-redirect">Prodrugs</a></div>
<p>Serotonin cannot be administered directly because when ingested orally, it will not cross the <a href="/wiki/Blood-brain_barrier" title="Blood-brain barrier">blood-brain barrier</a>, and therefore would have no effect on brain functions. Also, serotonin would activate <i>every</i> synapse it reaches, whereas SSRIs only <i>enhance a signal</i> that is already present, but too weak to come through. In addition, hope for breaching the blood-brain-barrier for causes such as severe depression are underway. The selectivity of the membrane can be reduced for a drug by injecting it in a concentrated sugar solution. The high osmotic pressure of the sugar solution causes the endothelial cells of the capillaries to shrink, which opens gaps between their tight junctions and makes the barrier more permeable. As a result the brain can enter the brain tissue</p>
<p><br /></p>
<p><a name="SSRIs_together_with_5-HT-Prodrugs" id="SSRIs_together_with_5-HT-Prodrugs"></a></p>
<h4><span class="editsection">[<a href="/w/index.php?title=Selective_serotonin_reuptake_inhibitor&amp;action=edit&amp;section=13" title="Edit section: SSRIs together with 5-HT-Prodrugs">edit</a>]</span> <span class="mw-headline">SSRIs together with 5-HT-Prodrugs</span></h4>
<p><a href="/wiki/Biosynthesis" title="Biosynthesis">Biosynthetically</a> serotonin is made from <a href="/wiki/Tryptophan" title="Tryptophan">tryptophan</a>, an <a href="/wiki/Amino_acid" title="Amino acid">amino acid</a>. If depression is caused by lack of serotonin, rather than insensitivity to it, SSRIs alone will not work well, whereas supplementing with tryptophan will.<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since February 2008" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup> In 1989, the <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration" class="mw-redirect">Food and Drug Administration</a> made tryptophan available by <a href="/wiki/Medical_prescription" title="Medical prescription">prescription</a> only, in response to an outbreak of <a href="/wiki/Eosinophilia-myalgia_syndrome" title="Eosinophilia-myalgia syndrome">eosinophilia-myalgia syndrome</a> caused by impure L-tryptophan supplements sold <a href="/wiki/Over-the-counter_drug" title="Over-the-counter drug">over-the-counter</a>. With current standards, L-tryptophan is again available over the counter in the US as well as supplement <a href="/wiki/5-HTP" title="5-HTP" class="mw-redirect">5-HTP</a> which is a direct precursor to serotonin.</p>
<p><a name="Adverse_effects" id="Adverse_effects"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Selective_serotonin_reuptake_inhibitor&amp;action=edit&amp;section=14" title="Edit section: Adverse effects">edit</a>]</span> <span class="mw-headline">Adverse effects</span></h2>
<p><a name="General_side_effects" id="General_side_effects"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Selective_serotonin_reuptake_inhibitor&amp;action=edit&amp;section=15" title="Edit section: General side effects">edit</a>]</span> <span class="mw-headline">General side effects</span></h3>
<p>General side effects are mostly present during the first 1-4 weeks while the body adapts to the drug (with the exception of sexual side effects, which tend to occur later in treatment). In fact, it often takes 6-8 weeks for the drug to begin reaching its full potential (the slow onset is considered a downside to treatment with SSRIs). Almost all SSRIs are known to cause one or more of these symptoms:</p>
<ul>
<li><a href="/wiki/Anhedonia" title="Anhedonia">anhedonia</a></li>
<li><a href="/wiki/Apathy" title="Apathy">apathy</a></li>
<li><a href="/wiki/Nausea" title="Nausea">nausea</a></li>
<li>drowsiness or <a href="/wiki/Somnolence" title="Somnolence">somnolence</a></li>
<li>headache</li>
<li>clenching of teeth</li>
<li>extremely vivid and strange dreams</li>
<li>dizziness</li>
<li>changes in appetite</li>
<li>weight loss/gain (measured by a change in bodyweight of 7 pounds)</li>
<li>may result in a double risk of <a href="/wiki/Bone_fracture" title="Bone fracture">bone fractures</a> and injuries</li>
<li>changes in <a href="/wiki/Human_sexual_behavior" title="Human sexual behavior">sexual behaviour</a> (see the next section)</li>
<li>increased feelings of depression and anxiety (which may sometimes provoke <a href="/wiki/Panic_attacks" title="Panic attacks" class="mw-redirect">panic attacks</a>)</li>
<li>tremors</li>
<li><a href="/wiki/Autonomic" title="Autonomic">autonomic</a> dysfunction including <a href="/wiki/Orthostatic_hypotension" title="Orthostatic hypotension">orthostatic hypotension</a>, increased or reduced <a href="/wiki/Sweating" title="Sweating" class="mw-redirect">sweating</a></li>
<li><a href="/wiki/Akathisia" title="Akathisia">akathisia</a></li>
<li>liver or <a href="/wiki/Renal_failure" title="Renal failure">renal impairment</a></li>
<li><a href="/wiki/Suicidal_ideation" title="Suicidal ideation">suicidal ideation</a> (thoughts of <a href="/wiki/Suicide" title="Suicide">suicide</a>)</li>
<li>Photosensitivity (increased risk of sunburn) (Use protective clothing, such as long sleeves and hats, and sunscreen to decrease the risk of sunburn.)<sup id="cite_ref-23" class="reference"><a href="#cite_note-23" title=""><span>[</span>24<span>]</span></a></sup></li>
</ul>
<p>Common gastrointestinal side effects include <a href="/wiki/Nausea" title="Nausea">nausea</a>, <a href="/wiki/Vomiting" title="Vomiting">vomiting</a>, and <a href="/wiki/Diarrhea" title="Diarrhea">diarrhea</a>, which are brought about by the actions of serotonin on the <a href="/wiki/Gastrointestinal_tract" title="Gastrointestinal tract">gastrointestinal tract</a>.</p>
<p>Most side effects usually disappear after the adaptation phase, when the antidepressive effects begin to show. However, despite being called general, the side effects and their durations are highly individual and drug-specific. Usually the treatment is begun with a small dose to see how the patient's body reacts to the drug, after that either the dose can be adjusted (eg. Prozac in the UK is begun at a 20&#160;mg dose, and then adjusted as necessary to 40&#160;mg or 60&#160;mg). Should the drug prove not to be effective, or the side effects intolerable to the patient, another common route is to switch treatment to either another SSRI, or an <a href="/wiki/Serotonin-norepinephrine_reuptake_inhibitor" title="Serotonin-norepinephrine reuptake inhibitor">SNRI</a>.<sup id="cite_ref-24" class="reference"><a href="#cite_note-24" title=""><span>[</span>25<span>]</span></a></sup></p>
<p><a href="/wiki/Mania" title="Mania">Mania</a> or <a href="/wiki/Hypomania" title="Hypomania">hypomania</a> is a possible side-effect. Users with some type of <a href="/wiki/Bipolar_disorder" title="Bipolar disorder">bipolar disorder</a> are at a much higher risk, however SSRI-induced mania in patients previously diagnosed with unipolar depression can trigger a bipolar diagnosis.</p>
<p><a name="Sexual_side_effects" id="Sexual_side_effects"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Selective_serotonin_reuptake_inhibitor&amp;action=edit&amp;section=16" title="Edit section: Sexual side effects">edit</a>]</span> <span class="mw-headline">Sexual side effects</span></h3>
<div class="rellink boilerplate seealso">See also: <a href="/wiki/Post_SSRI_Sexual_Dysfunction" title="Post SSRI Sexual Dysfunction" class="mw-redirect">Post SSRI Sexual Dysfunction</a></div>
<p>SSRIs can cause various types of <a href="/wiki/Sexual_dysfunction" title="Sexual dysfunction">sexual dysfunction</a> such as <a href="/wiki/Anorgasmia" title="Anorgasmia">anorgasmia</a>, <a href="/wiki/Erectile_dysfunction" title="Erectile dysfunction">erectile dysfunction</a>, and diminished <a href="/wiki/Libido" title="Libido">libido</a>. Initial studies found that such side effects occur in less than 10% of patients, but since these studies relied on unprompted reporting, the frequency was probably underestimated. In more recent studies, doctors have specifically asked about sexual difficulties, and found that they are present in between 17%<sup id="cite_ref-25" class="reference"><a href="#cite_note-25" title=""><span>[</span>26<span>]</span></a></sup> and 41%<sup id="cite_ref-26" class="reference"><a href="#cite_note-26" title=""><span>[</span>27<span>]</span></a></sup> of patients. This dysfunction occasionally disappears spontaneously without stopping the SSRI, and in most cases resolves after discontinuation. In some cases, however, it does not; this is known as <a href="/wiki/Post_SSRI_Sexual_Dysfunction" title="Post SSRI Sexual Dysfunction" class="mw-redirect">Post SSRI Sexual Dysfunction</a> (PSSD).</p>
<p>It is believed that sexual dysfunction is caused by an SSRI induced reduction in <a href="/wiki/Dopamine" title="Dopamine">dopamine</a>. Stimulation of postsynaptic 5-HT2 and 5-HT3 receptors decreases dopamine release from the <a href="/wiki/Substantia_nigra" title="Substantia nigra">Substantia Nigra</a>. A number of drugs are not associated with sexual side-effects (<a href="/wiki/Bupropion" title="Bupropion">bupropion</a>, <a href="/wiki/Mirtazapine" title="Mirtazapine">mirtazapine</a> (Remeron), <a href="/wiki/Maprotiline" title="Maprotiline">maprotiline</a> (Ludiomil), <a href="/wiki/Tianeptine" title="Tianeptine">tianeptine</a> (Stablon)<sup id="cite_ref-27" class="reference"><a href="#cite_note-27" title=""><span>[</span>28<span>]</span></a></sup><sup id="cite_ref-28" class="reference"><a href="#cite_note-28" title=""><span>[</span>29<span>]</span></a></sup> (some of these are also not associated with weight gain). As a result, sexual dysfunction caused by SSRIs can sometimes be mitigated by several different drugs. These include:</p>
<ul>
<li><a href="/wiki/Bupropion" title="Bupropion">bupropion</a> (<a href="/wiki/Norepinephrine_reuptake_inhibitor" title="Norepinephrine reuptake inhibitor">norepinephrine</a> and <a href="/wiki/Dopamine_reuptake_inhibitor" title="Dopamine reuptake inhibitor">dopamine reuptake inhibitor</a>)</li>
<li><a href="/wiki/Buspirone" title="Buspirone">buspirone</a> (<a href="/wiki/Serotonin_receptor_agonist" title="Serotonin receptor agonist">serotonin receptor agonist</a>)</li>
<li><a href="/wiki/Methylphenidate" title="Methylphenidate">methylphenidate</a> (stimulant)</li>
<li><a href="/wiki/Mirtazapine" title="Mirtazapine">mirtazapine</a> (<a href="/wiki/Noradrenergic_and_specific_serotonergic_antidepressant" title="Noradrenergic and specific serotonergic antidepressant" class="mw-redirect">noradrenergic and specific serotonergic antidepressant</a> (NaSSA))</li>
<li><a href="/wiki/Amphetamine" title="Amphetamine">amphetamine</a> (stimulant)</li>
<li><a href="/wiki/Amantadine" title="Amantadine">amantadine</a> (<a href="/wiki/Antiviral" title="Antiviral">antiviral</a>)</li>
<li><a href="/wiki/Pramipexole" title="Pramipexole">pramipexole</a> (<a href="/wiki/Dopamine_agonist" title="Dopamine agonist">dopamine agonist</a>) and</li>
<li><a href="/wiki/Ropinirole" title="Ropinirole">ropinirole</a> (<a href="/wiki/Dopamine_agonist" title="Dopamine agonist">dopamine agonist</a>)</li>
</ul>
<p>On the other hand, the effect of SSRIs to slow down sexual stimulation may be used as treatment; SSRIs have been proposed as a drug to treat <a href="/wiki/Premature_ejaculation" title="Premature ejaculation">premature ejaculation</a>.<sup id="cite_ref-29" class="reference"><a href="#cite_note-29" title=""><span>[</span>30<span>]</span></a></sup></p>
<p><a name="Cardiovascular_side_effects" id="Cardiovascular_side_effects"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Selective_serotonin_reuptake_inhibitor&amp;action=edit&amp;section=17" title="Edit section: Cardiovascular side effects">edit</a>]</span> <span class="mw-headline">Cardiovascular side effects</span></h3>
<p>Cardiovascular side effects are very rare with SSRI use, with a reported <a href="/wiki/Incidence_(epidemiology)" title="Incidence (epidemiology)">incidence</a> of less than 0.0003 percent.<sup id="cite_ref-30" class="reference"><a href="#cite_note-30" title=""><span>[</span>31<span>]</span></a></sup> SSRIs inhibit cardiac and vascular <a href="/wiki/Sodium_channel" title="Sodium channel">sodium</a>, <a href="/wiki/Calcium_channel" title="Calcium channel">calcium</a> and <a href="/wiki/Potassium_channel" title="Potassium channel">potassium channels</a> and prolong <a href="/wiki/QT_interval" title="QT interval">QT intervals</a>.<sup id="cite_ref-31" class="reference"><a href="#cite_note-31" title=""><span>[</span>32<span>]</span></a></sup> However, a number of large studies of patients without known pre-existing heart disease have reported no <a href="/wiki/Electrocardiogram" title="Electrocardiogram" class="mw-redirect">EKG</a> changes related to SSRI use.<sup id="cite_ref-afpssri_32-0" class="reference"><a href="#cite_note-afpssri-32" title=""><span>[</span>33<span>]</span></a></sup> In overdose, fluoxetine has been reported to cause <a href="/wiki/Sinus_tachycardia" title="Sinus tachycardia">sinus tachycardia</a>, <a href="/wiki/Myocardial_infarction" title="Myocardial infarction">myocardial infarction</a>, <a href="/wiki/Junctional_rhythm" title="Junctional rhythm">junctional rhythms</a> and <a href="/wiki/Trigeminy" title="Trigeminy" class="mw-redirect">trigeminy</a>. Some authors have suggested <a href="/wiki/Electrocardiogram" title="Electrocardiogram" class="mw-redirect">electrocardiographic</a> monitoring in patients with severe pre-existing cardiovascular disease who are taking SSRI's.<sup id="cite_ref-33" class="reference"><a href="#cite_note-33" title=""><span>[</span>34<span>]</span></a></sup></p>
<p><a name="Discontinuation_syndrome" id="Discontinuation_syndrome"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Selective_serotonin_reuptake_inhibitor&amp;action=edit&amp;section=18" title="Edit section: Discontinuation syndrome">edit</a>]</span> <span class="mw-headline">Discontinuation syndrome</span></h3>
<div class="rellink noprint relarticle mainarticle">Main article: <a href="/wiki/SSRI_discontinuation_syndrome" title="SSRI discontinuation syndrome">SSRI discontinuation syndrome</a></div>
<p><a href="/wiki/Antidepressants" title="Antidepressants" class="mw-redirect">Antidepressants</a> such as SSRIs have some <a href="/wiki/Dependence" title="Dependence" class="mw-redirect">dependence</a> producing effects, most notibly a <a href="/wiki/Withdrawal_syndrome" title="Withdrawal syndrome" class="mw-redirect">withdrawal syndrome</a>. However, their dependence producing properties are not as significant as <a href="/wiki/Benzodiazepines" title="Benzodiazepines" class="mw-redirect">benzodiazepines</a>. For example SSRIs have little to no <a href="/wiki/Drug_abuse" title="Drug abuse">abuse</a> potential unlike benzodiazepines.<sup id="cite_ref-34" class="reference"><a href="#cite_note-34" title=""><span>[</span>35<span>]</span></a></sup> SSRIs are addictive as discontinuing their use is known to produce both somatic and psychological <a href="/wiki/Withdrawal" title="Withdrawal">withdrawal symptoms</a>. Since <a href="/wiki/Physical_dependence" title="Physical dependence">physical dependence</a> is a reality, discontinuation should be discussed with a medical practitioner before beginning treatment with this class of drugs.</p>
<p><a name="Suicidality_and_aggression" id="Suicidality_and_aggression"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Selective_serotonin_reuptake_inhibitor&amp;action=edit&amp;section=19" title="Edit section: Suicidality and aggression">edit</a>]</span> <span class="mw-headline">Suicidality and aggression</span></h3>
<p>Similarly to other antidepressants, SSRIs can cause suicidality in children.<sup id="cite_ref-FDA_35-0" class="reference"><a href="#cite_note-FDA-35" title=""><span>[</span>36<span>]</span></a></sup><sup id="cite_ref-FDA2_36-0" class="reference"><a href="#cite_note-FDA2-36" title=""><span>[</span>37<span>]</span></a></sup><sup id="cite_ref-FDA3_37-0" class="reference"><a href="#cite_note-FDA3-37" title=""><span>[</span>38<span>]</span></a></sup> Analyses of the risks of SSRIs by governing bodies in the <a href="/wiki/United_States" title="United States">United States</a> and <a href="/wiki/United_Kingdom" title="United Kingdom">United Kingdom</a> have produced warnings about suicidality and aggression when the medications are used with children and adolescents.</p>
<p>A 2004 <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration" class="mw-redirect">Food and Drug Administration</a> (FDA) analysis of <a href="/wiki/Clinical_trial" title="Clinical trial">clinical trials</a> on children with <a href="/wiki/Major_depressive_disorder" title="Major depressive disorder">major depressive disorder</a> found statistically significant increases of the risks of "possible <a href="/wiki/Suicidal_ideation" title="Suicidal ideation">suicidal ideation</a> and suicidal behavior" by about 80%, and of agitation and hostility by about 130%.<sup id="cite_ref-FDA_35-1" class="reference"><a href="#cite_note-FDA-35" title=""><span>[</span>36<span>]</span></a></sup> An additional analysis by the FDA also indicated 1.5-fold increase of suicidality in the 18–24 age group.<sup id="cite_ref-FDA2_36-1" class="reference"><a href="#cite_note-FDA2-36" title=""><span>[</span>37<span>]</span></a></sup><sup id="cite_ref-FDA3_37-1" class="reference"><a href="#cite_note-FDA3-37" title=""><span>[</span>38<span>]</span></a></sup> This resulted in a <a href="/wiki/Black_box_warning" title="Black box warning">black box warning</a> on SSRI and other antidepressant medications regarding the increased risk of suicidality in patients younger than 24.<sup id="cite_ref-38" class="reference"><a href="#cite_note-38" title=""><span>[</span>39<span>]</span></a></sup></p>
<p>In 2004, the <a href="/wiki/Medicines_and_Healthcare_products_Regulatory_Agency" title="Medicines and Healthcare products Regulatory Agency">Medicines and Healthcare products Regulatory Agency</a> (MHRA) in the <a href="/wiki/United_Kingdom" title="United Kingdom">United Kingdom</a> judged <a href="/wiki/Fluoxetine" title="Fluoxetine">fluoxetine</a> (Prozac) to be the only antidepressant that offered a favorable <a href="/wiki/Risk-benefit_analysis" title="Risk-benefit analysis">risk-benefit ratio</a> in children with depression, though it was also associated with a slight increase in the risk of self-harm and suicidal ideation.<sup id="cite_ref-39" class="reference"><a href="#cite_note-39" title=""><span>[</span>40<span>]</span></a></sup> Only two SSRIs are licensed for use with children in the UK, <a href="/wiki/Sertraline" title="Sertraline">sertraline</a> (Zoloft) and <a href="/wiki/Fluvoxamine" title="Fluvoxamine">fluvoxamine</a> (Luvox), and only for the treatment of <a href="/wiki/Obsessive-compulsive_disorder" title="Obsessive-compulsive disorder">obsessive-compulsive disorder</a>. Fluoxetine, despite having a favorable risk-benefit ratio for use with depression in adolescents and children, is not licensed for this use.<sup id="cite_ref-MHRAoverview_40-0" class="reference"><a href="#cite_note-MHRAoverview-40" title=""><span>[</span>41<span>]</span></a></sup></p>
<p>Other studies on SSRIs and suicide among adolescents are equivocal; rates of suicide attempts in high-risk populations appear to be unaffected by SSRI prescriptions in adults.<sup id="cite_ref-41" class="reference"><a href="#cite_note-41" title=""><span>[</span>42<span>]</span></a></sup> There is also evidence that higher rates of SSRI prescriptions are associated with lower rates of suicide in children, though since the evidence is <a href="/wiki/Correlation" title="Correlation">correlational</a>, the true nature of the relationship is unclear.<sup id="cite_ref-pmid17074941_42-0" class="reference"><a href="#cite_note-pmid17074941-42" title=""><span>[</span>43<span>]</span></a></sup> The introduction of a warning regarding the association between SSRIs and suicide led to a decrease in prescriptions for the medications in 2003 and 2004, and these decreases in prescriptions were associated with an increase in actual number of teenage suicide.<sup id="cite_ref-pmid17728420_43-0" class="reference"><a href="#cite_note-pmid17728420-43" title=""><span>[</span>44<span>]</span></a></sup></p>
<p>In adults SSRIs overall reduce the incidence of suicide, however, in susceptible patients <a href="/wiki/Paradoxical_adverse_effects" title="Paradoxical adverse effects" class="mw-redirect">paradoxical adverse effects</a> can still occur which may precipitate suicide.<sup id="cite_ref-44" class="reference"><a href="#cite_note-44" title=""><span>[</span>45<span>]</span></a></sup></p>
<p><a name="SSRIs_and_pregnancy" id="SSRIs_and_pregnancy"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Selective_serotonin_reuptake_inhibitor&amp;action=edit&amp;section=20" title="Edit section: SSRIs and pregnancy">edit</a>]</span> <span class="mw-headline">SSRIs and pregnancy</span></h3>
<p>The <a href="/wiki/U.S._Food_and_Drug_Administration" title="U.S. Food and Drug Administration">U.S. Food and Drug Administration</a> issued a warning on July 19, 2006 stating nursing mothers on SSRIs must discuss treatment with their physicians.</p>
<p>When taken by <a href="/wiki/Pregnancy" title="Pregnancy">pregnant women</a>, selective serotonin reuptake inhibitors (SSRIs) cross the placenta and have the potential to affect newborns. <a href="/wiki/Sertraline" title="Sertraline">Sertraline</a> and <a href="/wiki/Paroxetine" title="Paroxetine">paroxetine</a> have been associated with <a href="/wiki/Congenital_disorder" title="Congenital disorder">congenital malformations</a>. Some evidence suggests that SSRIs are associated with neonatal complications such as <a href="/wiki/Neonatal_abstinence_syndrome" title="Neonatal abstinence syndrome" class="mw-redirect">neonatal abstinence syndrome</a> (NAS) and persistent <a href="/wiki/Pulmonary_hypertension" title="Pulmonary hypertension">pulmonary hypertension</a> (PPHN).</p>
<p><a name="Neonatal_abstinence_syndrome" id="Neonatal_abstinence_syndrome"></a></p>
<h4><span class="editsection">[<a href="/w/index.php?title=Selective_serotonin_reuptake_inhibitor&amp;action=edit&amp;section=21" title="Edit section: Neonatal abstinence syndrome">edit</a>]</span> <span class="mw-headline">Neonatal abstinence syndrome</span></h4>
<p><a href="/wiki/Neonatal_abstinence_syndrome" title="Neonatal abstinence syndrome" class="mw-redirect">Neonatal abstinence syndrome</a> is a <a href="/wiki/Withdrawal_syndrome" title="Withdrawal syndrome" class="mw-redirect">withdrawal syndrome</a> in <a href="/wiki/Infant" title="Infant">newborn babies</a>. It has been documented in SSRI treatment. By November 2003, a total of 93 cases of SSRI use associated with either neonatal convulsions or withdrawal syndrome had been reported. Subsequently, the authors of a <a href="/wiki/The_Lancet" title="The Lancet">Lancet</a> study concluded that doctors should avoid or cautiously manage the prescribing of these drugs to pregnant women with <a href="/wiki/Mental_illness" title="Mental illness" class="mw-redirect">psychiatric disorders</a>.<sup id="cite_ref-45" class="reference"><a href="#cite_note-45" title=""><span>[</span>46<span>]</span></a></sup></p>
<p><a name="Permanent_neuropsychological_changes" id="Permanent_neuropsychological_changes"></a></p>
<h4><span class="editsection">[<a href="/w/index.php?title=Selective_serotonin_reuptake_inhibitor&amp;action=edit&amp;section=22" title="Edit section: Permanent neuropsychological changes">edit</a>]</span> <span class="mw-headline">Permanent neuropsychological changes</span></h4>
<p>Since the early 80's scientists have used a technique called neonatal clomipramine to produce animals used in depression research. If rats are given the tricyclic antidepressant <a href="/wiki/Clomipramine" title="Clomipramine">clomipramine</a> when they are 8-21 days old they will develop behavioural changes in adulthood which resembles depression in humans.<sup id="cite_ref-pmid2183099_46-0" class="reference"><a href="#cite_note-pmid2183099-46" title=""><span>[</span>47<span>]</span></a></sup><sup id="cite_ref-pmid7902983_47-0" class="reference"><a href="#cite_note-pmid7902983-47" title=""><span>[</span>48<span>]</span></a></sup> In 1997 Lundbeck found that treatment with the SSRI LU-10-134-C, which only differs from their product citalopram by two atoms could give similar results as clomipramine.<sup id="cite_ref-pmid9400008_48-0" class="reference"><a href="#cite_note-pmid9400008-48" title=""><span>[</span>49<span>]</span></a></sup> Later it was found that neonatal citalopram and escitalopram makes persistent changes in the serotonergic transmission of the brain resulting in behavioral changes, <sup id="cite_ref-pmid18385313_49-0" class="reference"><a href="#cite_note-pmid18385313-49" title=""><span>[</span>50<span>]</span></a></sup><sup id="cite_ref-pmid16012532_50-0" class="reference"><a href="#cite_note-pmid16012532-50" title=""><span>[</span>51<span>]</span></a></sup> which are reversed by treatment with antidepressants.<sup id="cite_ref-pmid16483567_51-0" class="reference"><a href="#cite_note-pmid16483567-51" title=""><span>[</span>52<span>]</span></a></sup> By treating normal and <a href="/wiki/Knockout_mouse" title="Knockout mouse">knockout mice</a> lacking the serotonin transporter with fluoxetine scientists showed that normal emotional reactions in adulthood, like a short latency to escape foot shocks and inclination to explore new environments were dependent on active serotonin transporters during the neonatal period.<sup id="cite_ref-52" class="reference"><a href="#cite_note-52" title=""><span>[</span>53<span>]</span></a></sup><sup id="cite_ref-53" class="reference"><a href="#cite_note-53" title=""><span>[</span>54<span>]</span></a></sup></p>
<p>But when young mice were treated with the SNRI desimipramine they developed to normal adults, which suggests that serotonin and noradrenaline has different effects in the developing brain. For humans, the developmental stage sensitive to SSRI:s corresponds with the last trimester to the first years of life. A study showed that 4-year old children perinatally exposed to SSRI:s behave normally, however the young mice and rats also seems to be normal until they reach puberty and develop their behavioural disturbances.<sup id="cite_ref-54" class="reference"><a href="#cite_note-54" title=""><span>[</span>55<span>]</span></a></sup><sup id="cite_ref-pmid16741203_55-0" class="reference"><a href="#cite_note-pmid16741203-55" title=""><span>[</span>56<span>]</span></a></sup></p>
<p>The mechanism is currently unknown, but it seems that early life overstimulation of the 5HT-1 receptor which acts like a thermostat for the serotonin production results in low serotonin production after puberty.<sup id="cite_ref-56" class="reference"><a href="#cite_note-56" title=""><span>[</span>57<span>]</span></a></sup></p>
<p><a name="Persistent_pulmonary_hypertension" id="Persistent_pulmonary_hypertension"></a></p>
<h4><span class="editsection">[<a href="/w/index.php?title=Selective_serotonin_reuptake_inhibitor&amp;action=edit&amp;section=23" title="Edit section: Persistent pulmonary hypertension">edit</a>]</span> <span class="mw-headline">Persistent pulmonary hypertension</span></h4>
<p>Persistent <a href="/wiki/Pulmonary_hypertension" title="Pulmonary hypertension">pulmonary hypertension</a> (PPHN) is a serious and life-threatening, but rare, lung condition that occurs soon after birth of the newborn. <a href="/wiki/Infant" title="Infant">Newborn babies</a> with PPHN have high pressure in their lung <a href="/wiki/Blood_vessel" title="Blood vessel">blood vessels</a> and are not able to get enough oxygen into their bloodstream. About 1 to 2 babies per 1000 babies born in the U.S. develop PPHN shortly after birth, and often they need intensive <a href="/wiki/Health_care" title="Health care">medical care</a>. One study has found that PPHN is six times more common in babies whose mothers take an SSRI antidepressant after the 20th week of the pregnancy compared to babies whose mothers do not take an antidepressant.<sup id="cite_ref-57" class="reference"><a href="#cite_note-57" title=""><span>[</span>58<span>]</span></a></sup></p>
<p><a name="Interaction_with_carbohydrate_metabolism" id="Interaction_with_carbohydrate_metabolism"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Selective_serotonin_reuptake_inhibitor&amp;action=edit&amp;section=24" title="Edit section: Interaction with carbohydrate metabolism">edit</a>]</span> <span class="mw-headline">Interaction with carbohydrate metabolism</span></h3>
<p>Serotonin is also involved in regulation of <a href="/wiki/Carbohydrate_metabolism" title="Carbohydrate metabolism">carbohydrate metabolism</a>. Few analyses of the role of SSRIs in treating depression cover the effects on carbohydrate metabolism from intervening in serotonin handling by the body.</p>
<p><a name="Overdose" id="Overdose"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Selective_serotonin_reuptake_inhibitor&amp;action=edit&amp;section=25" title="Edit section: Overdose">edit</a>]</span> <span class="mw-headline">Overdose</span></h2>
<div class="rellink noprint relarticle mainarticle">Main article: <a href="/wiki/Serotonin_syndrome" title="Serotonin syndrome">Serotonin syndrome</a></div>
<p>SSRIs appear to be safer in <a href="/wiki/Overdose" title="Overdose" class="mw-redirect">overdose</a> when compared with traditional antidepressants such as the tricyclic antidepressants. This relative safety is supported both by case series and studies of deaths per numbers of prescriptions.<sup id="cite_ref-ClinTox2004-isbister_58-0" class="reference"><a href="#cite_note-ClinTox2004-isbister-58" title=""><span>[</span>59<span>]</span></a></sup> However, case reports of SSRI poisoning have indicated that severe toxicity can occur<sup id="cite_ref-AmJEmergMed1992-Borys_59-0" class="reference"><a href="#cite_note-AmJEmergMed1992-Borys-59" title=""><span>[</span>60<span>]</span></a></sup> and deaths have been reported following massive single ingestions,<sup id="cite_ref-Lancet1996-Ostrom_60-0" class="reference"><a href="#cite_note-Lancet1996-Ostrom-60" title=""><span>[</span>61<span>]</span></a></sup> although this is exceedingly uncommon when compared to the tricyclic antidepressants.<sup id="cite_ref-ClinTox2004-isbister_58-1" class="reference"><a href="#cite_note-ClinTox2004-isbister-58" title=""><span>[</span>59<span>]</span></a></sup></p>
<p>Because of the wide <a href="/wiki/Therapeutic_index" title="Therapeutic index">therapeutic index</a> of the SSRIs, most patients will have mild or no symptoms following moderate overdoses. The most commonly reported severe effect following SSRI overdose is <a href="/wiki/Serotonin_syndrome" title="Serotonin syndrome">serotonin syndrome</a>; serotonin toxicity is usually associated with very high overdoses or multiple drug ingestion.<sup id="cite_ref-DrugSaf1995-Sporer_61-0" class="reference"><a href="#cite_note-DrugSaf1995-Sporer-61" title=""><span>[</span>62<span>]</span></a></sup> Other reported significant effects include <a href="/wiki/Coma" title="Coma">coma</a>, <a href="/wiki/Seizures" title="Seizures" class="mw-redirect">seizures</a>, and <a href="/wiki/Cardiotoxicity" title="Cardiotoxicity">cardiac toxicity</a>.<sup id="cite_ref-ClinTox2004-isbister_58-2" class="reference"><a href="#cite_note-ClinTox2004-isbister-58" title=""><span>[</span>59<span>]</span></a></sup></p>
<p>Treatment for SSRI overdose is mainly based on symptomatic and supportive care. Medical care may be required for agitation, maintenance of the airways, and treatment for serotonin syndrome. <a href="/wiki/ECG" title="ECG" class="mw-redirect">ECG</a> monitoring is usually indicated to detect any cardiac abnormalities.</p>
<p><a name="Criticism" id="Criticism"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Selective_serotonin_reuptake_inhibitor&amp;action=edit&amp;section=26" title="Edit section: Criticism">edit</a>]</span> <span class="mw-headline">Criticism</span></h2>
<div class="rellink boilerplate seealso">See also: <a href="/wiki/Biopsychiatry_controversy" title="Biopsychiatry controversy">Biopsychiatry controversy</a>&#160;and <a href="/wiki/Biological_psychiatry" title="Biological psychiatry">Biological psychiatry</a></div>
<p>In late 2004 media attention was given to a proposed link between SSRI use and <a href="/wiki/Teenage_suicide" title="Teenage suicide">juvenile suicide</a>. For this reason, the use of SSRIs in pediatric cases of depression is now recognized by the United States FDA as warranting a cautionary statement to the parents of children who may be prescribed SSRIs by a <a href="/wiki/General_practitioner" title="General practitioner">family doctor</a>. The FDA's currently required packaging insert for SSRIs includes a warning (known as a <a href="/wiki/Black_box_warning" title="Black box warning">"black box warning"</a>) that a pooled analysis of placebo <a href="/wiki/Randomized_controlled_trial" title="Randomized controlled trial">controlled trials</a> of 9 antidepressant drugs (including multiple SSRIs) resulted in a risk of suicidality that was twice that of <a href="/wiki/Placebo" title="Placebo">placebo</a>. At the same time, in adults SSRIs do not increase the risk of suicide.<sup id="cite_ref-pmid15718537_62-0" class="reference"><a href="#cite_note-pmid15718537-62" title=""><span>[</span>63<span>]</span></a></sup></p>
<p>Critics of SSRIs claim that the widely-disseminated television and print advertising of SSRIs promotes an inaccurate message, oversimplifying what these medications actually do and deceiving the public.<sup id="cite_ref-63" class="reference"><a href="#cite_note-63" title=""><span>[</span>64<span>]</span></a></sup></p>
<p>The criticism stems from questions about the validity of claims that SSRIs work by 'correcting' <a href="/wiki/Chemical_imbalance_theory" title="Chemical imbalance theory" class="mw-redirect">chemical imbalances</a>. Without accurately measuring patients' <a href="/wiki/Neurotransmitter" title="Neurotransmitter">neurotransmitter</a> levels to allow for continuous monitoring during treatment, it is impossible to know if one is correctly targeting a deficient neurotransmitter (i.e. correcting an imbalance), reaching a desirable level, or even introducing too much of a particular neurotransmitter. Thus it has been argued that SSRIs can actually cause chemical imbalances and abnormal brain states. Hence it is purported that when a patient discontinues an SSRI, they may have a chemical imbalance due to the rapid cessation of the drug which is causing the discontinuation syndrome.<sup id="cite_ref-64" class="reference"><a href="#cite_note-64" title=""><span>[</span>65<span>]</span></a></sup></p>
<p>One possible mechanism is by inhibition of <a href="/wiki/Dopamine" title="Dopamine">dopaminergic</a> neurotransmission.<sup id="cite_ref-65" class="reference"><a href="#cite_note-65" title=""><span>[</span>66<span>]</span></a></sup></p>
<p>Biopsychiatrists believe that, among other factors, the balance of <a href="/wiki/Neurotransmitter" title="Neurotransmitter">neurotransmitters</a> in the <a href="/wiki/Brain" title="Brain">brain</a> is a biological regulator of <a href="/wiki/Mental_health" title="Mental health">mental health</a>. In this theory, emotions within a "normal" spectrum reflect a proper balance of neurochemicals, but abnormally extreme emotions, such as <a href="/wiki/Clinical_depression" title="Clinical depression" class="mw-redirect">clinical depression</a>, reflect an imbalance. Psychiatrists claim that medications regulate neurotransmitters, and many if not most psychiatrists also claim they treat abnormal personalities by removing a neurochemical excess or replenishing a deficit (though the efficacy of <a href="/wiki/Antidepressants" title="Antidepressants" class="mw-redirect">antidepressants</a> and <a href="/wiki/Antipsychotics" title="Antipsychotics" class="mw-redirect">antipsychotics</a> is not undisputed<sup id="cite_ref-66" class="reference"><a href="#cite_note-66" title=""><span>[</span>67<span>]</span></a></sup>). On the other hand, <a href="/wiki/Elliot_Valenstein" title="Elliot Valenstein">Elliot Valenstein</a>, a psychologist and neuroscientist, claims that the broad biochemical assertions and assumptions of mainstream psychiatry are not supported by evidence.<sup id="cite_ref-67" class="reference"><a href="#cite_note-67" title=""><span>[</span>68<span>]</span></a></sup></p>
<p>One controversial critic of antidepressants, <a href="/wiki/Peter_Breggin" title="Peter Breggin">Peter Breggin</a>, a physician who opposes the overuse of prescription medications to treat patients for mental health issues, predicted <a href="/wiki/Iatrogenesis" title="Iatrogenesis">iatrogenic</a> issues that SSRIs incur on a significant percentage of patients. Another prominent SSRI critic is <a href="/wiki/David_Healy_(psychiatrist)" title="David Healy (psychiatrist)">David Healy</a>.</p>
<p>A widely-reported meta-analysis combined 35 clinical trials submitted to the <a href="/wiki/U.S._Food_and_Drug_Administration" title="U.S. Food and Drug Administration">U.S. Food and Drug Administration</a> (FDA) before licensing of four newer antidepressants (including the SSRIs <a href="/wiki/Paroxetine" title="Paroxetine">paroxetine</a> and <a href="/wiki/Fluoxetine" title="Fluoxetine">fluoxetine</a>, and two non-SSRI antidepressants <a href="/wiki/Nefazodone" title="Nefazodone">nefazodone</a> and <a href="/wiki/Venlafaxine" title="Venlafaxine">venlafaxine</a>). The authors found that although the antidepressants were <a href="/wiki/Statistically" title="Statistically" class="mw-redirect">statistically</a> superior to <a href="/wiki/Placebo" title="Placebo">placebo</a> they did not exceed the <a href="/wiki/NICE" title="NICE" class="mw-redirect">NICE</a> criteria for a 'clinically significant' effect. In particular they found that the effect size was very small for moderate depression but increased with severity reaching 'clinical significance' for very severe depression. The relationship between severity and efficacy was attributed to a reduction of the placebo effect in severely depressed patients, rather than an increase in the effect of the medication.<sup id="cite_ref-68" class="reference"><a href="#cite_note-68" title=""><span>[</span>69<span>]</span></a></sup> <sup id="cite_ref-69" class="reference"><a href="#cite_note-69" title=""><span>[</span>70<span>]</span></a></sup> <sup id="cite_ref-70" class="reference"><a href="#cite_note-70" title=""><span>[</span>71<span>]</span></a></sup> <sup id="cite_ref-71" class="reference"><a href="#cite_note-71" title=""><span>[</span>72<span>]</span></a></sup> <sup id="cite_ref-72" class="reference"><a href="#cite_note-72" title=""><span>[</span>73<span>]</span></a></sup> <sup id="cite_ref-73" class="reference"><a href="#cite_note-73" title=""><span>[</span>74<span>]</span></a></sup></p>
<p>A study in the <a href="/wiki/New_England_Journal_of_Medicine" title="New England Journal of Medicine">New England Journal of Medicine</a> on a possible <a href="/wiki/Publication_bias" title="Publication bias">publication bias</a> regarding the efficacy of SSRI medications in the treatment of depression suggests that their effectiveness and risk-benefit ratios may be greatly exaggerated. Of 74 studies registered with the United States <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration" class="mw-redirect">FDA</a>, 37 with positive results were published in <a href="/wiki/Academic_journal" title="Academic journal">academic journals</a>, while 22 studies with negative results were not published and 11 with negative results were published in a way that conveyed a positive outcome (one positive study was not published and three negative studies were published with results that were portrayed as negative). Overall, 94% of studies actually published were positive outcomes; when published and unpublished studies were included for analysis, the percentage of positive outcomes was 51%.<sup id="cite_ref-pmid18199864_74-0" class="reference"><a href="#cite_note-pmid18199864-74" title=""><span>[</span>75<span>]</span></a></sup></p>
<p><a name="Lawsuits" id="Lawsuits"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Selective_serotonin_reuptake_inhibitor&amp;action=edit&amp;section=27" title="Edit section: Lawsuits">edit</a>]</span> <span class="mw-headline">Lawsuits</span></h2>
<p>Hundreds of lawsuits have been filed against drug manufacturers seeking compensation for harm attributed to the use of SSRIs. Suits based on <a href="/wiki/Product_liability" title="Product liability">product liability</a>, for example, often allege failure to adequately warn users of potential side effects. Manufacturers have defended many suits on the merits and settled many others. In 2005, the U.S. Food and Drug Administration (FDA) asked manufacturers to include <a href="/wiki/Black_box_warnings" title="Black box warnings" class="mw-redirect">black box warnings</a> on antidepressant drug packaging.<sup id="cite_ref-75" class="reference"><a href="#cite_note-75" title=""><span>[</span>76<span>]</span></a></sup> The inclusion of the black box warning may have lead to a decrease in prescriptions of SSRIs and an increase in suicide. <sup id="cite_ref-76" class="reference"><a href="#cite_note-76" title=""><span>[</span>77<span>]</span></a></sup><sup id="cite_ref-77" class="reference"><a href="#cite_note-77" title=""><span>[</span>78<span>]</span></a></sup></p>
<p><a name="See_also" id="See_also"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Selective_serotonin_reuptake_inhibitor&amp;action=edit&amp;section=28" title="Edit section: See also">edit</a>]</span> <span class="mw-headline">See also</span></h2>
<ul>
<li><a href="/wiki/SSRI_discontinuation_syndrome" title="SSRI discontinuation syndrome">SSRI discontinuation syndrome</a></li>
<li><a href="/wiki/Serotonin/Norepinephrine/Dopamine_Reuptake_Inhibitor" title="Serotonin/Norepinephrine/Dopamine Reuptake Inhibitor" class="mw-redirect">Serotonin/Norepinephrine/Dopamine Reuptake Inhibitor</a></li>
<li><a href="/wiki/SSRI_discontinuation_syndrome#List_of_SSRIs" title="SSRI discontinuation syndrome">List of SSRI medications</a></li>
</ul>
<p><a name="References_and_notes" id="References_and_notes"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Selective_serotonin_reuptake_inhibitor&amp;action=edit&amp;section=29" title="Edit section: References and notes">edit</a>]</span> <span class="mw-headline">References and notes</span></h2>
<div class="references-small references-column-count references-column-count-2" style="-moz-column-count:2; column-count:2;">
<ol class="references">
<li id="cite_note-BARLOW-0"><b><a href="#cite_ref-BARLOW_0-0" title="">^</a></b> <cite style="font-style:normal" class="book" id="CITEREFBarlow.2C_David_H._Durand.2C_V._Mark2009">Barlow, David H. Durand, V. Mark (2009). "Chapter 7: Mood Disorders and Suicide". <i>Abnormal Psychology: An Integrative Approach</i> (Fifth ed.). Belmont, CA: Wadsworth Cengage Learning. pp.&#160;239. <a href="/wiki/Special:BookSources/0495095567" class="internal">ISBN 0495095567</a>. <a href="/wiki/Online_Computer_Library_Center" title="Online Computer Library Center">OCLC</a> <a href="http://worldcat.org/oclc/192055408" class="external text" title="http://worldcat.org/oclc/192055408" rel="nofollow">192055408</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Chapter+7%3A+Mood+Disorders+and+Suicide&amp;rft.atitle=Abnormal+Psychology%3A+An+Integrative+Approach&amp;rft.aulast=Barlow%2C+David+H.+Durand%2C+V.+Mark&amp;rft.au=Barlow%2C+David+H.+Durand%2C+V.+Mark&amp;rft.date=2009&amp;rft.pages=pp.%26nbsp%3B239&amp;rft.edition=Fifth&amp;rft.place=Belmont%2C+CA&amp;rft.pub=Wadsworth+Cengage+Learning&amp;rft_id=info:oclcnum/192055408&amp;rft.isbn=0495095567&amp;rfr_id=info:sid/en.wikipedia.org:Selective_serotonin_reuptake_inhibitor"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-1"><b><a href="#cite_ref-1" title="">^</a></b> (Chapter) <cite style="font-style:normal" class="" id="CITEREFSheldon_H._Preskorn.2C_Christina_Y._Stanga.2C_Ruth_Ross">Sheldon H. Preskorn, Christina Y. Stanga, Ruth Ross, <i>Selective serotonin reuptake inhibitor</i>, pp.&#160;242</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Selective+serotonin+reuptake+inhibitor&amp;rft.aulast=Sheldon+H.+Preskorn%2C+Christina+Y.+Stanga%2C+Ruth+Ross&amp;rft.au=Sheldon+H.+Preskorn%2C+Christina+Y.+Stanga%2C+Ruth+Ross&amp;rft.pages=pp.%26nbsp%3B242&amp;rfr_id=info:sid/en.wikipedia.org:Selective_serotonin_reuptake_inhibitor"><span style="display: none;">&#160;</span></span> in <cite style="font-style:normal" class="" id="CITEREFSheldon_H._Preskorn.2C_Christina_Y._Stanga.2C_John_P._Feighner.2C_Ruth_Ross_.28Editors.292004">Sheldon H. Preskorn, Christina Y. Stanga, John P. Feighner, Ruth Ross (Editors) (2004), <i>Antidepressants: Past, Present, and Future</i>, Springer, <a href="/wiki/Special:BookSources/3540430547" class="internal">ISBN 3540430547</a></cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Antidepressants%3A+Past%2C+Present%2C+and+Future&amp;rft.aulast=Sheldon+H.+Preskorn%2C+Christina+Y.+Stanga%2C+John+P.+Feighner%2C+Ruth+Ross+%28Editors%29&amp;rft.au=Sheldon+H.+Preskorn%2C+Christina+Y.+Stanga%2C+John+P.+Feighner%2C+Ruth+Ross+%28Editors%29&amp;rft.date=2004&amp;rft.pub=Springer&amp;rft.isbn=3540430547&amp;rfr_id=info:sid/en.wikipedia.org:Selective_serotonin_reuptake_inhibitor"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17983899-2"><b><a href="#cite_ref-pmid17983899_2-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFWaldinger_MD2007">Waldinger MD (2007). "Premature ejaculation: state of the art". <i>Urol. Clin. North Am.</i> <b>34</b> (4): 591–9, vii–viii. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.ucl.2007.08.011" class="external text" title="http://dx.doi.org/10.1016%2Fj.ucl.2007.08.011" rel="nofollow">10.1016/j.ucl.2007.08.011</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17983899" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17983899">PMID 17983899</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Premature+ejaculation%3A+state+of+the+art&amp;rft.jtitle=Urol.+Clin.+North+Am.&amp;rft.aulast=Waldinger+MD&amp;rft.au=Waldinger+MD&amp;rft.date=2007&amp;rft.volume=34&amp;rft.issue=4&amp;rft.pages=591%E2%80%939%2C+vii%E2%80%93viii&amp;rft_id=info:doi/10.1016%2Fj.ucl.2007.08.011&amp;rft_id=info:pmid/17983899&amp;rfr_id=info:sid/en.wikipedia.org:Selective_serotonin_reuptake_inhibitor"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid15363569-3"><b><a href="#cite_ref-pmid15363569_3-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFWaldinger_MD.2C_Zwinderman_AH.2C_Olivier_B2004">Waldinger MD, Zwinderman AH, Olivier B (2004). "On-demand treatment of premature ejaculation with clomipramine and paroxetine: a randomized, double-blind fixed-dose study with stopwatch assessment". <i>Eur. Urol.</i> <b>46</b> (4): 510–5; discussion 516. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.eururo.2004.05.005" class="external text" title="http://dx.doi.org/10.1016%2Fj.eururo.2004.05.005" rel="nofollow">10.1016/j.eururo.2004.05.005</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15363569" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15363569">PMID 15363569</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=On-demand+treatment+of+premature+ejaculation+with+clomipramine+and+paroxetine%3A+a+randomized%2C+double-blind+fixed-dose+study+with+stopwatch+assessment&amp;rft.jtitle=Eur.+Urol.&amp;rft.aulast=Waldinger+MD%2C+Zwinderman+AH%2C+Olivier+B&amp;rft.au=Waldinger+MD%2C+Zwinderman+AH%2C+Olivier+B&amp;rft.date=2004&amp;rft.volume=46&amp;rft.issue=4&amp;rft.pages=510%E2%80%935%3B+discussion+516&amp;rft_id=info:doi/10.1016%2Fj.eururo.2004.05.005&amp;rft_id=info:pmid/15363569&amp;rfr_id=info:sid/en.wikipedia.org:Selective_serotonin_reuptake_inhibitor"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid11313839-4">^ <a href="#cite_ref-pmid11313839_4-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid11313839_4-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid11313839_4-2" title=""><sup><i><b>c</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFAbdel-Hamid_IA.2C_El_Naggar_EA.2C_El_Gilany_AH2001">Abdel-Hamid IA, El Naggar EA, El Gilany AH (2001). "Assessment of as needed use of pharmacotherapy and the pause-squeeze technique in premature ejaculation". <i>Int. J. Impot. Res.</i> <b>13</b> (1): 41–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1038%2Fsj.ijir.3900630" class="external text" title="http://dx.doi.org/10.1038%2Fsj.ijir.3900630" rel="nofollow">10.1038/sj.ijir.3900630</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11313839" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11313839">PMID 11313839</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Assessment+of+as+needed+use+of+pharmacotherapy+and+the+pause-squeeze+technique+in+premature+ejaculation&amp;rft.jtitle=Int.+J.+Impot.+Res.&amp;rft.aulast=Abdel-Hamid+IA%2C+El+Naggar+EA%2C+El+Gilany+AH&amp;rft.au=Abdel-Hamid+IA%2C+El+Naggar+EA%2C+El+Gilany+AH&amp;rft.date=2001&amp;rft.volume=13&amp;rft.issue=1&amp;rft.pages=41%E2%80%935&amp;rft_id=info:doi/10.1038%2Fsj.ijir.3900630&amp;rft_id=info:pmid/11313839&amp;rfr_id=info:sid/en.wikipedia.org:Selective_serotonin_reuptake_inhibitor"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17470165-5">^ <a href="#cite_ref-pmid17470165_5-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid17470165_5-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFWang_WF.2C_Wang_Y.2C_Minhas_S.2C_Ralph_DJ2007">Wang WF, Wang Y, Minhas S, Ralph DJ (2007). "Can sildenafil treat primary premature ejaculation? A prospective clinical study". <i>Int. J. Urol.</i> <b>14</b> (4): 331–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1111%2Fj.1442-2042.2007.01606.x" class="external text" title="http://dx.doi.org/10.1111%2Fj.1442-2042.2007.01606.x" rel="nofollow">10.1111/j.1442-2042.2007.01606.x</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17470165" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17470165">PMID 17470165</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Can+sildenafil+treat+primary+premature+ejaculation%3F+A+prospective+clinical+study&amp;rft.jtitle=Int.+J.+Urol.&amp;rft.aulast=Wang+WF%2C+Wang+Y%2C+Minhas+S%2C+Ralph+DJ&amp;rft.au=Wang+WF%2C+Wang+Y%2C+Minhas+S%2C+Ralph+DJ&amp;rft.date=2007&amp;rft.volume=14&amp;rft.issue=4&amp;rft.pages=331%E2%80%935&amp;rft_id=info:doi/10.1111%2Fj.1442-2042.2007.01606.x&amp;rft_id=info:pmid/17470165&amp;rfr_id=info:sid/en.wikipedia.org:Selective_serotonin_reuptake_inhibitor"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-6"><b><a href="#cite_ref-6" title="">^</a></b> <a href="http://www.emedicinehealth.com/ssris_and_depression/page4_em.htm" class="external text" title="http://www.emedicinehealth.com/ssris_and_depression/page4_em.htm" rel="nofollow">SSRIs and Depression</a></li>
<li id="cite_note-7"><b><a href="#cite_ref-7" title="">^</a></b> <a href="http://www.ncbi.nlm.nih.gov/pubmed/17096399" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17096399">PMID 17096399</a>. Rasmussen-Torvik LJ, McAlpine DD. <a href="/wiki/Genetic_testing" title="Genetic testing">Genetic screening</a> for SSRI drug response among those with major depression: great promise and unseen perils. Depress Anxiety. 2006 Nov 9</li>
<li id="cite_note-8"><b><a href="#cite_ref-8" title="">^</a></b> <a href="http://www.ncbi.nlm.nih.gov/pubmed/14514498" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/14514498">PMID 14514498</a>. Murphy GM Jr, Kremer C, Rodrigues HE, Schatzberg AF. Pharmacogenetics of antidepressant medication intolerance. Am J Psychiatry. 2003 Oct;160(10):1830-5.</li>
<li id="cite_note-9"><b><a href="#cite_ref-9" title="">^</a></b> Malberg JE et al. (2000): "Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus" <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11124987&amp;query_hl=14&amp;itool=pubmed_docsum" class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11124987&amp;query_hl=14&amp;itool=pubmed_docsum" rel="nofollow">J. Neurosci. 20 (24), 9104-10</a></li>
<li id="cite_note-10"><b><a href="#cite_ref-10" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFLevkovitz_Y_et._al.2005">Levkovitz Y et. al. (2005). "Differential induction of apoptosis by antidepressants in glioma and neuroblastoma cell lines Evidence for p-c-Jun, cytochrome c, and caspase-3 involvement". <i>Journal of Molecular Neuroscience</i> <b>27</b> (1): 29–42.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Differential+induction+of+apoptosis+by+antidepressants+in+glioma+and+neuroblastoma+cell+lines%0AEvidence+for+p-c-Jun%2C+cytochrome+c%2C+and+caspase-3+involvement&amp;rft.jtitle=Journal+of+Molecular+Neuroscience&amp;rft.aulast=Levkovitz+Y+et.+al.&amp;rft.au=Levkovitz+Y+et.+al.&amp;rft.date=2005&amp;rft.volume=27&amp;rft.issue=1&amp;rft.pages=29%E2%80%9342&amp;rfr_id=info:sid/en.wikipedia.org:Selective_serotonin_reuptake_inhibitor"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-11"><b><a href="#cite_ref-11" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFSerafeim_A_et._al.2003">Serafeim A et. al. (2003). "Selective serotonin reuptake inhibitors directly signal for apoptosis in biopsy-like Burkitt lymphoma cells". <i>Blood</i> <b>101</b> (8): 3212–3219.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Selective+serotonin+reuptake+inhibitors+directly+signal+for+apoptosis+in+biopsy-like+Burkitt+lymphoma+cells&amp;rft.jtitle=Blood&amp;rft.aulast=Serafeim+A+et.+al.&amp;rft.au=Serafeim+A+et.+al.&amp;rft.date=2003&amp;rft.volume=101&amp;rft.issue=8&amp;rft.pages=3212%E2%80%933219&amp;rfr_id=info:sid/en.wikipedia.org:Selective_serotonin_reuptake_inhibitor"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-12"><b><a href="#cite_ref-12" title="">^</a></b> O'Brien SM, Scully P, Scott LV, Dinan TG. (2006). Cytokine profiles in bipolar affective disorder: focus on acutely ill patients. <i>J Affect Disord.</i>, Feb, <i>90</i>(2-3), 263-267.</li>
<li id="cite_note-13"><b><a href="#cite_ref-13" title="">^</a></b> Obuchowicz E, Marcinowska A, Herman ZS. (2005). Antidepressants and cytokines: clinical and experimental studies <i>Psychiatr Pol.</i>, Sep-Oct, <i>39</i>(5), 921-936.</li>
<li id="cite_note-14"><b><a href="#cite_ref-14" title="">^</a></b> Hong CJ, Yu YW, Chen TJ, Tsai SJ. Interleukin-6 genetic polymorphism and Chinese major depression. <i>Neuropsychobiology</i>, <i>52</i>(4), 202-205.</li>
<li id="cite_note-15"><b><a href="#cite_ref-15" title="">^</a></b> Elenkov IJ, Iezzoni DG, Daly A, Harris AG, Chrousos GP. (2005). Abstract cytokine dysregulation, inflammation and well-being. <i>Neuroimmunomodulation</i>, <i>12</i>(5), 255-269.</li>
<li id="cite_note-16"><b><a href="#cite_ref-16" title="">^</a></b> Kubera M, Maes M, Kenis G, Kim YK, Lason W. (2005). Effects of serotonin and serotonergic agonists and antagonists on the production of tumor necrosis factor alpha and interleukin-6. <i>Psychiatry Res.</i>, Apr 30, <i>134</i>(3), 251-258.</li>
<li id="cite_note-17"><b><a href="#cite_ref-17" title="">^</a></b> Diamond M, Kelly JP, Connor TJ. (2006). Antidepressants suppress production of the Th1 cytokine interferon-gamma, independent of monoamine transporter blockade. <i>Eur Neuropsychopharmacol.</i>, Oct, <i>16</i>(7):481-490.</li>
<li id="cite_note-18"><b><a href="#cite_ref-18" title="">^</a></b> Kubera M, Lin AH, Kenis G, Bosmans E, van Bockstaele D, Maes M. (2001). Anti-inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio. <i>J Clin Psychopharmacol.</i>, Apr, <i>21</i>(2):199-206.</li>
<li id="cite_note-19"><b><a href="#cite_ref-19" title="">^</a></b> Maes M. (2001). The immunoregulatory effects of antidepressants. <i>Hum Psychopharmacol.</i>, Jan, <i>16</i>(1):95-103.</li>
<li id="cite_note-20"><b><a href="#cite_ref-20" title="">^</a></b> Maes M, Kenis G, Kubera M, De Baets M, Steinbusch H, Bosmans E. (2005). The negative immunoregulatory effects of fluoxetine in relation to the cAMP-dependent PKA pathway. <i>Int Immunopharmacol.</i>, Mar, <i>5</i>(3):609-618.</li>
<li id="cite_note-21"><b><a href="#cite_ref-21" title="">^</a></b> O'Brien SM, Scott LV, Dinan TG. (2004). Cytokines: abnormalities in major depression and implications for pharmacological treatment. <i>Hum Psychopharmacol.</i>, Aug, <i>19</i>(6), 397-403.</li>
<li id="cite_note-22"><b><a href="#cite_ref-22" title="">^</a></b> Anderson IM (2000): "Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a <a href="/wiki/Meta-analysis" title="Meta-analysis">meta-analysis</a> of efficacy and tolerability", <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=10760555&amp;dopt=Citation" class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=10760555&amp;dopt=Citation" rel="nofollow">J. Affect. Disord. 58(1), 19-3</a></li>
<li id="cite_note-23"><b><a href="#cite_ref-23" title="">^</a></b> <a href="http://www.emedicinehealth.com/ssris_and_depression/page5_em.htm" class="external text" title="http://www.emedicinehealth.com/ssris_and_depression/page5_em.htm" rel="nofollow">SSRIs and Depression</a></li>
<li id="cite_note-24"><b><a href="#cite_ref-24" title="">^</a></b> A landmark study in the use of anti-depressants and their role in step-therapy can be found in the STAR*D trial.</li>
<li id="cite_note-25"><b><a href="#cite_ref-25" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFHu_XH_et_al2004">Hu XH et al (2004). "Incidence and duration of side effects and those rated as bothersome with selective serotonin reuptake inhibitor treatment for depression: patient report versus physician estimate". <i>J Clin Psychiatry</i> <b>65</b>: 959–65. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15291685" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15291685">PMID 15291685</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Incidence+and+duration+of+side+effects+and+those+rated+as+bothersome+with+selective+serotonin+reuptake+inhibitor+treatment+for+depression%3A+patient+report+versus+physician+estimate&amp;rft.jtitle=J+Clin+Psychiatry&amp;rft.aulast=Hu+XH+et+al&amp;rft.au=Hu+XH+et+al&amp;rft.date=2004&amp;rft.volume=65&amp;rft.pages=959%E2%80%9365&amp;rft_id=info:pmid/15291685&amp;rfr_id=info:sid/en.wikipedia.org:Selective_serotonin_reuptake_inhibitor"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-26"><b><a href="#cite_ref-26" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFLanden_M.2C_Hogberg_P.2C_Thase_ME2005">Landen M, Hogberg P, Thase ME (2005). "Incidence of sexual side effects in refractory depression during treatment with citalopram or paroxetine". <i>J Clin Psychiatry</i> <b>66</b>: 100–6. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15669895" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15669895">PMID 15669895</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Incidence+of+sexual+side+effects+in+refractory+depression+during+treatment+with+citalopram+or+paroxetine&amp;rft.jtitle=J+Clin+Psychiatry&amp;rft.aulast=Landen+M%2C+Hogberg+P%2C+Thase+ME&amp;rft.au=Landen+M%2C+Hogberg+P%2C+Thase+ME&amp;rft.date=2005&amp;rft.volume=66&amp;rft.pages=100%E2%80%936&amp;rft_id=info:pmid/15669895&amp;rfr_id=info:sid/en.wikipedia.org:Selective_serotonin_reuptake_inhibitor"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-27"><b><a href="#cite_ref-27" title="">^</a></b> For the review, see: <cite style="font-style:normal" class="" id="CITEREFClayton_AH2003">Clayton AH (2003). "Antidepressant-Associated Sexual Dysfunction: A Potentially Avoidable Therapeutic Challenge". <i>Primary Psychiatry</i> <b>10</b> (1): 55–61.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Antidepressant-Associated+Sexual+Dysfunction%3A+A+Potentially+Avoidable+Therapeutic+Challenge&amp;rft.jtitle=Primary+Psychiatry&amp;rft.aulast=Clayton+AH&amp;rft.au=Clayton+AH&amp;rft.date=2003&amp;rft.volume=10&amp;rft.issue=1&amp;rft.pages=55%E2%80%9361&amp;rfr_id=info:sid/en.wikipedia.org:Selective_serotonin_reuptake_inhibitor"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-28"><b><a href="#cite_ref-28" title="">^</a></b> For another review, see: <cite style="font-style:normal" class="" id="CITEREFKanaly_KA.2C_Berman_JR2002">Kanaly KA, Berman JR (2002). "Sexual side effects of SSRI medications: potential treatment strategies for SSRI-induced female sexual dysfunction". <i>Curr Women's Health Rep</i> <b>2</b> (6): 409–16. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12429073" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12429073">PMID 12429073</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Sexual+side+effects+of+SSRI+medications%3A+potential+treatment+strategies+for+SSRI-induced+female+sexual+dysfunction&amp;rft.jtitle=Curr+Women%27s+Health+Rep&amp;rft.aulast=Kanaly+KA%2C+Berman+JR&amp;rft.au=Kanaly+KA%2C+Berman+JR&amp;rft.date=2002&amp;rft.volume=2&amp;rft.issue=6&amp;rft.pages=409%E2%80%9316&amp;rft_id=info:pmid/12429073&amp;rfr_id=info:sid/en.wikipedia.org:Selective_serotonin_reuptake_inhibitor"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-29"><b><a href="#cite_ref-29" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFWaldinger_MD.2C_Olivier_B.2004">Waldinger MD, Olivier B. (July), "Utility of selective serotonin reuptake inhibitors in premature ejaculation", <i>Curr Opin Investig Drugs</i> <b>5</b> (7): 743–7, <a href="http://www.ncbi.nlm.nih.gov/pubmed/15298071" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15298071">PMID 15298071</a></cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Utility+of+selective+serotonin+reuptake+inhibitors+in+premature+ejaculation&amp;rft.jtitle=Curr+Opin+Investig+Drugs&amp;rft.aulast=Waldinger+MD%2C+Olivier+B.&amp;rft.au=Waldinger+MD%2C+Olivier+B.&amp;rft.date=July&amp;rft.volume=5&amp;rft.issue=7&amp;rft.pages=743%E2%80%937&amp;rft_id=info:pmid/15298071&amp;rfr_id=info:sid/en.wikipedia.org:Selective_serotonin_reuptake_inhibitor"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-30"><b><a href="#cite_ref-30" title="">^</a></b> Grace Brooke Huffman. "Cardiac effects in patients using SSRI antidepressants - selective serotonin reuptake inhibitor - Tips from Other Journals". <a href="/wiki/American_Family_Physician" title="American Family Physician">American Family Physician</a>, August, 1997.</li>
<li id="cite_note-31"><b><a href="#cite_ref-31" title="">^</a></b> Pacher P, Kecskemeti V."Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns?". Curr Pharm Des. 2004;10(20):2463-2475. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15320756" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15320756">PMID 15320756</a></li>
<li id="cite_note-afpssri-32"><b><a href="#cite_ref-afpssri_32-0" title="">^</a></b> <a href="http://archfami.ama-assn.org/cgi/content/full/7/1/78" class="external autonumber" title="http://archfami.ama-assn.org/cgi/content/full/7/1/78" rel="nofollow">[1]</a> Richard J. Goldberg, MD. Selective Serotonin Reuptake Inhibitors: Infrequent Medical Adverse Effects. Arch Fam Med. 1998;7:78-84.</li>
<li id="cite_note-33"><b><a href="#cite_ref-33" title="">^</a></b> Pacher P, Ungvari Z, Nanasi PP, Furst S, Kecskemeti V."Speculations on difference between tricyclic and selective serotonin reuptake inhibitor antidepressants on their cardiac effects. Is there any?". Curr Med Chem. 1999 Jun;6(6):469-80. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10213794" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/10213794">PMID 10213794</a></li>
<li id="cite_note-34"><b><a href="#cite_ref-34" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFvan_Broekhoven_F.2C_Kan_CC.2C_Zitman_FG2002">van Broekhoven F, Kan CC, Zitman FG (June 2002). "<a href="http://linkinghub.elsevier.com/retrieve/pii/S0278-5846(02)00209-9" class="external text" title="http://linkinghub.elsevier.com/retrieve/pii/S0278-5846(02)00209-9" rel="nofollow">Dependence potential of antidepressants compared to benzodiazepines</a>". <i>Prog. Neuropsychopharmacol. Biol. Psychiatry</i> <b>26</b> (5): 939–43. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12369270" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12369270">PMID 12369270</a><span class="printonly">. <a href="http://linkinghub.elsevier.com/retrieve/pii/S0278-5846(02)00209-9" class="external free" title="http://linkinghub.elsevier.com/retrieve/pii/S0278-5846(02)00209-9" rel="nofollow">http://linkinghub.elsevier.com/retrieve/pii/S0278-5846(02)00209-9</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Dependence+potential+of+antidepressants+compared+to+benzodiazepines&amp;rft.jtitle=Prog.+Neuropsychopharmacol.+Biol.+Psychiatry&amp;rft.aulast=van+Broekhoven+F%2C+Kan+CC%2C+Zitman+FG&amp;rft.au=van+Broekhoven+F%2C+Kan+CC%2C+Zitman+FG&amp;rft.date=June+2002&amp;rft.volume=26&amp;rft.issue=5&amp;rft.pages=939%E2%80%9343&amp;rft_id=info:pmid/12369270&amp;rft_id=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0278-5846%2802%2900209-9&amp;rfr_id=info:sid/en.wikipedia.org:Selective_serotonin_reuptake_inhibitor"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-FDA-35">^ <a href="#cite_ref-FDA_35-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FDA_35-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="web" id="CITEREFHammad_TA">Hammad TA (2004-08-116). <a href="http://www.fda.gov/OHRMS/DOCKETS/ac/04/briefing/2004-4065b1-10-TAB08-Hammads-Review.pdf" class="external text" title="http://www.fda.gov/OHRMS/DOCKETS/ac/04/briefing/2004-4065b1-10-TAB08-Hammads-Review.pdf" rel="nofollow">"Review and evaluation of clinical data. Relationship between psychiatric drugs and pediatric suicidality."</a> (PDF). FDA. 42; 115<span class="printonly">. <a href="http://www.fda.gov/OHRMS/DOCKETS/ac/04/briefing/2004-4065b1-10-TAB08-Hammads-Review.pdf" class="external free" title="http://www.fda.gov/OHRMS/DOCKETS/ac/04/briefing/2004-4065b1-10-TAB08-Hammads-Review.pdf" rel="nofollow">http://www.fda.gov/OHRMS/DOCKETS/ac/04/briefing/2004-4065b1-10-TAB08-Hammads-Review.pdf</a></span><span class="reference-accessdate">. Retrieved on 2008-05-29</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Review+and+evaluation+of+clinical+data.+Relationship+between+psychiatric+drugs+and+pediatric+suicidality.&amp;rft.atitle=&amp;rft.aulast=Hammad+TA&amp;rft.au=Hammad+TA&amp;rft.date=2004-08-116&amp;rft.pages=42%3B+115&amp;rft.pub=FDA&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2FOHRMS%2FDOCKETS%2Fac%2F04%2Fbriefing%2F2004-4065b1-10-TAB08-Hammads-Review.pdf&amp;rfr_id=info:sid/en.wikipedia.org:Selective_serotonin_reuptake_inhibitor"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-FDA2-36">^ <a href="#cite_ref-FDA2_36-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FDA2_36-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="web" id="CITEREFStone_MB.2C_Jones_ML2006">Stone MB, Jones ML (2006-11-17). <a href="http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4272b1-01-FDA.pdf" class="external text" title="http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4272b1-01-FDA.pdf" rel="nofollow">"Clinical review: relationship between antidepressant drugs and suicidality in adults"</a> (PDF). <i>Overview for December 13 Meeting of Psychopharmacologic Drugs Advisory Committee (PDAC)</i>. FDA. 11–74<span class="printonly">. <a href="http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4272b1-01-FDA.pdf" class="external free" title="http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4272b1-01-FDA.pdf" rel="nofollow">http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4272b1-01-FDA.pdf</a></span><span class="reference-accessdate">. Retrieved on 2007-09-22</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Clinical+review%3A+relationship+between+antidepressant+drugs+and+suicidality+in+adults&amp;rft.atitle=Overview+for+December+13+Meeting+of+Psychopharmacologic+Drugs+Advisory+Committee+%28PDAC%29&amp;rft.aulast=Stone+MB%2C+Jones+ML&amp;rft.au=Stone+MB%2C+Jones+ML&amp;rft.date=2006-11-17&amp;rft.pages=11%E2%80%9374&amp;rft.pub=FDA&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2Fohrms%2Fdockets%2Fac%2F06%2Fbriefing%2F2006-4272b1-01-FDA.pdf&amp;rfr_id=info:sid/en.wikipedia.org:Selective_serotonin_reuptake_inhibitor"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-FDA3-37">^ <a href="#cite_ref-FDA3_37-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FDA3_37-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="web" id="CITEREFLevenson_M.2C_Holland_C2006">Levenson M, Holland C (2006-11-17). <a href="http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4272b1-01-FDA.pdf" class="external text" title="http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4272b1-01-FDA.pdf" rel="nofollow">"Statistical Evaluation of Suicidality in Adults Treated with Antidepressants"</a> (PDF). <i>Overview for December 13 Meeting of Psychopharmacologic Drugs Advisory Committee (PDAC)</i>. FDA. 75–140<span class="printonly">. <a href="http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4272b1-01-FDA.pdf" class="external free" title="http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4272b1-01-FDA.pdf" rel="nofollow">http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4272b1-01-FDA.pdf</a></span><span class="reference-accessdate">. Retrieved on 2007-09-22</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Statistical+Evaluation+of+Suicidality+in+Adults+Treated+with+Antidepressants&amp;rft.atitle=Overview+for+December+13+Meeting+of+Psychopharmacologic+Drugs+Advisory+Committee+%28PDAC%29&amp;rft.aulast=Levenson+M%2C+Holland+C&amp;rft.au=Levenson+M%2C+Holland+C&amp;rft.date=2006-11-17&amp;rft.pages=75%E2%80%93140&amp;rft.pub=FDA&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2Fohrms%2Fdockets%2Fac%2F06%2Fbriefing%2F2006-4272b1-01-FDA.pdf&amp;rfr_id=info:sid/en.wikipedia.org:Selective_serotonin_reuptake_inhibitor"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-38"><b><a href="#cite_ref-38" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://www.fda.gov/bbs/topics/NEWS/2007/NEW01624.html" class="external text" title="http://www.fda.gov/bbs/topics/NEWS/2007/NEW01624.html" rel="nofollow">"FDA Proposes New Warnings About Suicidal Thinking, Behavior in Young Adults Who Take Antidepressant Medications"</a> (htm). <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration" class="mw-redirect">FDA</a>. 2007-05-02<span class="printonly">. <a href="http://www.fda.gov/bbs/topics/NEWS/2007/NEW01624.html" class="external free" title="http://www.fda.gov/bbs/topics/NEWS/2007/NEW01624.html" rel="nofollow">http://www.fda.gov/bbs/topics/NEWS/2007/NEW01624.html</a></span><span class="reference-accessdate">. Retrieved on 2008-05-29</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=FDA+Proposes+New+Warnings+About+Suicidal+Thinking%2C+Behavior+in+Young+Adults+Who+Take+Antidepressant+Medications&amp;rft.atitle=&amp;rft.date=2007-05-02&amp;rft.pub=%5B%5BFood+and+Drug+Administration%7CFDA%5D%5D&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2Fbbs%2Ftopics%2FNEWS%2F2007%2FNEW01624.html&amp;rfr_id=info:sid/en.wikipedia.org:Selective_serotonin_reuptake_inhibitor"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-39"><b><a href="#cite_ref-39" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://www.mhra.gov.uk/home/groups/pl-p/documents/drugsafetymessage/con019472.pdf" class="external text" title="http://www.mhra.gov.uk/home/groups/pl-p/documents/drugsafetymessage/con019472.pdf" rel="nofollow">"Report of the CSM expert working group on the safety of selective serotonin reuptake inhibitor antidepressants"</a> (PDF). <a href="/wiki/Medicines_and_Healthcare_products_Regulatory_Agency" title="Medicines and Healthcare products Regulatory Agency">MHRA</a>. 2004-12-01<span class="printonly">. <a href="http://www.mhra.gov.uk/home/groups/pl-p/documents/drugsafetymessage/con019472.pdf" class="external free" title="http://www.mhra.gov.uk/home/groups/pl-p/documents/drugsafetymessage/con019472.pdf" rel="nofollow">http://www.mhra.gov.uk/home/groups/pl-p/documents/drugsafetymessage/con019472.pdf</a></span><span class="reference-accessdate">. Retrieved on 2007-09-25</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Report+of+the+CSM+expert+working+group+on+the+safety+of+selective+serotonin+reuptake+inhibitor+antidepressants&amp;rft.atitle=&amp;rft.date=2004-12-01&amp;rft.pub=%5B%5BMedicines+and+Healthcare+products+Regulatory+Agency%7CMHRA%5D%5D&amp;rft_id=http%3A%2F%2Fwww.mhra.gov.uk%2Fhome%2Fgroups%2Fpl-p%2Fdocuments%2Fdrugsafetymessage%2Fcon019472.pdf&amp;rfr_id=info:sid/en.wikipedia.org:Selective_serotonin_reuptake_inhibitor"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-MHRAoverview-40"><b><a href="#cite_ref-MHRAoverview_40-0" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://www.mhra.gov.uk/Safetyinformation/Safetywarningsalertsandrecalls/Safetywarningsandmessagesformedicines/CON019494" class="external text" title="http://www.mhra.gov.uk/Safetyinformation/Safetywarningsalertsandrecalls/Safetywarningsandmessagesformedicines/CON019494" rel="nofollow">"Selective Serotonin Reuptake Inhibitors (SSRIs): Overview of regulatory status and CSM advice relating to major depressive disorder (MDD) in children and adolescents including a summary of available safety and efficacy data"</a>. <a href="/wiki/Medicines_and_Healthcare_products_Regulatory_Agency" title="Medicines and Healthcare products Regulatory Agency">MHRA</a>. 2005-09-29<span class="printonly">. <a href="http://www.mhra.gov.uk/Safetyinformation/Safetywarningsalertsandrecalls/Safetywarningsandmessagesformedicines/CON019494" class="external free" title="http://www.mhra.gov.uk/Safetyinformation/Safetywarningsalertsandrecalls/Safetywarningsandmessagesformedicines/CON019494" rel="nofollow">http://www.mhra.gov.uk/Safetyinformation/Safetywarningsalertsandrecalls/Safetywarningsandmessagesformedicines/CON019494</a></span><span class="reference-accessdate">. Retrieved on 2008-05-29</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Selective+Serotonin+Reuptake+Inhibitors+%28SSRIs%29%3A+Overview+of+regulatory+status+and+CSM+advice+relating+to+major+depressive+disorder+%28MDD%29+in+children+and+adolescents+including+a+summary+of+available+safety+and+efficacy+data&amp;rft.atitle=&amp;rft.date=2005-09-29&amp;rft.pub=%5B%5BMedicines+and+Healthcare+products+Regulatory+Agency%7CMHRA%5D%5D&amp;rft_id=http%3A%2F%2Fwww.mhra.gov.uk%2FSafetyinformation%2FSafetywarningsalertsandrecalls%2FSafetywarningsandmessagesformedicines%2FCON019494&amp;rfr_id=info:sid/en.wikipedia.org:Selective_serotonin_reuptake_inhibitor"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-41"><b><a href="#cite_ref-41" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFOlfson_M.2C_Marcus_SC.2C_Shaffer_D2006">Olfson M, Marcus SC, Shaffer D (August 2006). "Antidepressant drug therapy and suicide in severely depressed children and adults: A case-control study". <i>Arch. Gen. Psychiatry</i> <b>63</b> (8): 865–72. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1001%2Farchpsyc.63.8.865" class="external text" title="http://dx.doi.org/10.1001%2Farchpsyc.63.8.865" rel="nofollow">10.1001/archpsyc.63.8.865</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16894062" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16894062">PMID 16894062</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Antidepressant+drug+therapy+and+suicide+in+severely+depressed+children+and+adults%3A+A+case-control+study&amp;rft.jtitle=Arch.+Gen.+Psychiatry&amp;rft.aulast=Olfson+M%2C+Marcus+SC%2C+Shaffer+D&amp;rft.au=Olfson+M%2C+Marcus+SC%2C+Shaffer+D&amp;rft.date=August+2006&amp;rft.volume=63&amp;rft.issue=8&amp;rft.pages=865%E2%80%9372&amp;rft_id=info:doi/10.1001%2Farchpsyc.63.8.865&amp;rft_id=info:pmid/16894062&amp;rfr_id=info:sid/en.wikipedia.org:Selective_serotonin_reuptake_inhibitor"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17074941-42"><b><a href="#cite_ref-pmid17074941_42-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFGibbons_RD.2C_Hur_K.2C_Bhaumik_DK.2C_Mann_JJ2006">Gibbons RD, Hur K, Bhaumik DK, Mann JJ (November 2006). "<a href="http://ajp.psychiatryonline.org/cgi/content/full/163/11/1898" class="external text" title="http://ajp.psychiatryonline.org/cgi/content/full/163/11/1898" rel="nofollow">The relationship between antidepressant prescription rates and rate of early adolescent suicide</a>". <i>Am J Psychiatry</i> <b>163</b> (11): 1898–904. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1176%2Fappi.ajp.163.11.1898" class="external text" title="http://dx.doi.org/10.1176%2Fappi.ajp.163.11.1898" rel="nofollow">10.1176/appi.ajp.163.11.1898</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17074941" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17074941">PMID 17074941</a><span class="printonly">. <a href="http://ajp.psychiatryonline.org/cgi/content/full/163/11/1898" class="external free" title="http://ajp.psychiatryonline.org/cgi/content/full/163/11/1898" rel="nofollow">http://ajp.psychiatryonline.org/cgi/content/full/163/11/1898</a></span><span class="reference-accessdate">. Retrieved on 2008-05-29</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+relationship+between+antidepressant+prescription+rates+and+rate+of+early+adolescent+suicide&amp;rft.jtitle=Am+J+Psychiatry&amp;rft.aulast=Gibbons+RD%2C+Hur+K%2C+Bhaumik+DK%2C+Mann+JJ&amp;rft.au=Gibbons+RD%2C+Hur+K%2C+Bhaumik+DK%2C+Mann+JJ&amp;rft.date=November+2006&amp;rft.volume=163&amp;rft.issue=11&amp;rft.pages=1898%E2%80%93904&amp;rft_id=info:doi/10.1176%2Fappi.ajp.163.11.1898&amp;rft_id=info:pmid/17074941&amp;rft_id=http%3A%2F%2Fajp.psychiatryonline.org%2Fcgi%2Fcontent%2Ffull%2F163%2F11%2F1898&amp;rfr_id=info:sid/en.wikipedia.org:Selective_serotonin_reuptake_inhibitor"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17728420-43"><b><a href="#cite_ref-pmid17728420_43-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFGibbons_RD.2C_Brown_CH.2C_Hur_K.2C_.27.27et_al.27.272007">Gibbons RD, Brown CH, Hur K, <i>et al</i> (September 2007). "<a href="http://ajp.psychiatryonline.org/cgi/content/full/164/9/1356" class="external text" title="http://ajp.psychiatryonline.org/cgi/content/full/164/9/1356" rel="nofollow">Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents</a>". <i>Am J Psychiatry</i> <b>164</b> (9): 1356–63. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1176%2Fappi.ajp.2007.07030454" class="external text" title="http://dx.doi.org/10.1176%2Fappi.ajp.2007.07030454" rel="nofollow">10.1176/appi.ajp.2007.07030454</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17728420" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17728420">PMID 17728420</a><span class="printonly">. <a href="http://ajp.psychiatryonline.org/cgi/content/full/164/9/1356" class="external free" title="http://ajp.psychiatryonline.org/cgi/content/full/164/9/1356" rel="nofollow">http://ajp.psychiatryonline.org/cgi/content/full/164/9/1356</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Early+evidence+on+the+effects+of+regulators%27+suicidality+warnings+on+SSRI+prescriptions+and+suicide+in+children+and+adolescents&amp;rft.jtitle=Am+J+Psychiatry&amp;rft.aulast=Gibbons+RD%2C+Brown+CH%2C+Hur+K%2C+%27%27et+al%27%27&amp;rft.au=Gibbons+RD%2C+Brown+CH%2C+Hur+K%2C+%27%27et+al%27%27&amp;rft.date=September+2007&amp;rft.volume=164&amp;rft.issue=9&amp;rft.pages=1356%E2%80%9363&amp;rft_id=info:doi/10.1176%2Fappi.ajp.2007.07030454&amp;rft_id=info:pmid/17728420&amp;rft_id=http%3A%2F%2Fajp.psychiatryonline.org%2Fcgi%2Fcontent%2Ffull%2F164%2F9%2F1356&amp;rfr_id=info:sid/en.wikipedia.org:Selective_serotonin_reuptake_inhibitor"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-44"><b><a href="#cite_ref-44" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFNishida_T.2C_Wada_M.2C_Wada_M.2C_Ito_H.2C_Narabayashi_M.2C_Onishi_H2008">Nishida T, Wada M, Wada M, Ito H, Narabayashi M, Onishi H (June 2008). "<a href="http://journals.cambridge.org/abstract_S1478951508000278" class="external text" title="http://journals.cambridge.org/abstract_S1478951508000278" rel="nofollow">Activation syndrome caused by paroxetine in a cancer patient</a>". <i>Palliat Support Care</i> <b>6</b> (2): 183–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1017%2FS1478951508000278" class="external text" title="http://dx.doi.org/10.1017%2FS1478951508000278" rel="nofollow">10.1017/S1478951508000278</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18501054" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/18501054">PMID 18501054</a><span class="printonly">. <a href="http://journals.cambridge.org/abstract_S1478951508000278" class="external free" title="http://journals.cambridge.org/abstract_S1478951508000278" rel="nofollow">http://journals.cambridge.org/abstract_S1478951508000278</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Activation+syndrome+caused+by+paroxetine+in+a+cancer+patient&amp;rft.jtitle=Palliat+Support+Care&amp;rft.aulast=Nishida+T%2C+Wada+M%2C+Wada+M%2C+Ito+H%2C+Narabayashi+M%2C+Onishi+H&amp;rft.au=Nishida+T%2C+Wada+M%2C+Wada+M%2C+Ito+H%2C+Narabayashi+M%2C+Onishi+H&amp;rft.date=June+2008&amp;rft.volume=6&amp;rft.issue=2&amp;rft.pages=183%E2%80%935&amp;rft_id=info:doi/10.1017%2FS1478951508000278&amp;rft_id=info:pmid/18501054&amp;rft_id=http%3A%2F%2Fjournals.cambridge.org%2Fabstract_S1478951508000278&amp;rfr_id=info:sid/en.wikipedia.org:Selective_serotonin_reuptake_inhibitor"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-45"><b><a href="#cite_ref-45" title="">^</a></b> <a href="http://www.medicalnewstoday.com/medicalnews.php?newsid=19631" class="external autonumber" title="http://www.medicalnewstoday.com/medicalnews.php?newsid=19631" rel="nofollow">[2]</a> <a href="/wiki/Medical_News_Today" title="Medical News Today">Medical News Today</a> - Lancet Press Release. Feb 05 2005</li>
<li id="cite_note-pmid2183099-46"><b><a href="#cite_ref-pmid2183099_46-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFVogel_G.2C_Neill_D.2C_Hagler_M.2C_Kors_D1990">Vogel G, Neill D, Hagler M, Kors D (1990). "<a href="http://linkinghub.elsevier.com/retrieve/pii/S0149-7634(05)80164-2" class="external text" title="http://linkinghub.elsevier.com/retrieve/pii/S0149-7634(05)80164-2" rel="nofollow">A new animal model of endogenous depression: a summary of present findings</a>". <i>Neurosci Biobehav Rev</i> <b>14</b> (1): 85–91. <a href="http://www.ncbi.nlm.nih.gov/pubmed/2183099" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/2183099">PMID 2183099</a><span class="printonly">. <a href="http://linkinghub.elsevier.com/retrieve/pii/S0149-7634(05)80164-2" class="external free" title="http://linkinghub.elsevier.com/retrieve/pii/S0149-7634(05)80164-2" rel="nofollow">http://linkinghub.elsevier.com/retrieve/pii/S0149-7634(05)80164-2</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+new+animal+model+of+endogenous+depression%3A+a+summary+of+present+findings&amp;rft.jtitle=Neurosci+Biobehav+Rev&amp;rft.aulast=Vogel+G%2C+Neill+D%2C+Hagler+M%2C+Kors+D&amp;rft.au=Vogel+G%2C+Neill+D%2C+Hagler+M%2C+Kors+D&amp;rft.date=1990&amp;rft.volume=14&amp;rft.issue=1&amp;rft.pages=85%E2%80%9391&amp;rft_id=info:pmid/2183099&amp;rft_id=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0149-7634%2805%2980164-2&amp;rfr_id=info:sid/en.wikipedia.org:Selective_serotonin_reuptake_inhibitor"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid7902983-47"><b><a href="#cite_ref-pmid7902983_47-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFVelazquez-Moctezuma_J.2C_Aguilar-Garcia_A.2C_Diaz-Ruiz_O1993">Velazquez-Moctezuma J, Aguilar-Garcia A, Diaz-Ruiz O (September 1993). "<a href="http://linkinghub.elsevier.com/retrieve/pii/0091-3057(93)90343-R" class="external text" title="http://linkinghub.elsevier.com/retrieve/pii/0091-3057(93)90343-R" rel="nofollow">Behavioral effects of neonatal treatment with clomipramine, scopolamine, and idazoxan in male rats</a>". <i>Pharmacol. Biochem. Behav.</i> <b>46</b> (1): 215–7. <a href="http://www.ncbi.nlm.nih.gov/pubmed/7902983" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/7902983">PMID 7902983</a><span class="printonly">. <a href="http://linkinghub.elsevier.com/retrieve/pii/0091-3057(93)90343-R" class="external free" title="http://linkinghub.elsevier.com/retrieve/pii/0091-3057(93)90343-R" rel="nofollow">http://linkinghub.elsevier.com/retrieve/pii/0091-3057(93)90343-R</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Behavioral+effects+of+neonatal+treatment+with+clomipramine%2C+scopolamine%2C+and+idazoxan+in+male+rats&amp;rft.jtitle=Pharmacol.+Biochem.+Behav.&amp;rft.aulast=Velazquez-Moctezuma+J%2C+Aguilar-Garcia+A%2C+Diaz-Ruiz+O&amp;rft.au=Velazquez-Moctezuma+J%2C+Aguilar-Garcia+A%2C+Diaz-Ruiz+O&amp;rft.date=September+1993&amp;rft.volume=46&amp;rft.issue=1&amp;rft.pages=215%E2%80%937&amp;rft_id=info:pmid/7902983&amp;rft_id=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2F0091-3057%2893%2990343-R&amp;rfr_id=info:sid/en.wikipedia.org:Selective_serotonin_reuptake_inhibitor"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid9400008-48"><b><a href="#cite_ref-pmid9400008_48-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFHansen_HH.2C_S.C3.A1nchez_C.2C_Meier_E1997">Hansen HH, Sánchez C, Meier E (December 1997). "<a href="http://jpet.aspetjournals.org/cgi/pmidlookup?view=long&amp;pmid=9400008" class="external text" title="http://jpet.aspetjournals.org/cgi/pmidlookup?view=long&amp;pmid=9400008" rel="nofollow">Neonatal administration of the selective serotonin reuptake inhibitor Lu 10-134-C increases forced swimming-induced immobility in adult rats: a putative animal model of depression?</a>". <i>J. Pharmacol. Exp. Ther.</i> <b>283</b> (3): 1333–41. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9400008" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9400008">PMID 9400008</a><span class="printonly">. <a href="http://jpet.aspetjournals.org/cgi/pmidlookup?view=long&amp;pmid=9400008" class="external free" title="http://jpet.aspetjournals.org/cgi/pmidlookup?view=long&amp;pmid=9400008" rel="nofollow">http://jpet.aspetjournals.org/cgi/pmidlookup?view=long&amp;pmid=9400008</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Neonatal+administration+of+the+selective+serotonin+reuptake+inhibitor+Lu+10-134-C+increases+forced+swimming-induced+immobility+in+adult+rats%3A+a+putative+animal+model+of+depression%3F&amp;rft.jtitle=J.+Pharmacol.+Exp.+Ther.&amp;rft.aulast=Hansen+HH%2C+S%C3%A1nchez+C%2C+Meier+E&amp;rft.au=Hansen+HH%2C+S%C3%A1nchez+C%2C+Meier+E&amp;rft.date=December+1997&amp;rft.volume=283&amp;rft.issue=3&amp;rft.pages=1333%E2%80%9341&amp;rft_id=info:pmid/9400008&amp;rft_id=http%3A%2F%2Fjpet.aspetjournals.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D9400008&amp;rfr_id=info:sid/en.wikipedia.org:Selective_serotonin_reuptake_inhibitor"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid18385313-49"><b><a href="#cite_ref-pmid18385313_49-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFPopa_D.2C_L.C3.A9na_C.2C_Alexandre_C.2C_Adrien_J2008">Popa D, Léna C, Alexandre C, Adrien J (2008). "<a href="http://www.jneurosci.org/cgi/content/abstract/28/14/3546" class="external text" title="http://www.jneurosci.org/cgi/content/abstract/28/14/3546" rel="nofollow">Lasting syndrome of depression produced by reduction in serotonin uptake during postnatal development: evidence from sleep, stress, and behavior.</a>". <i>J Neurosci.</i> <b>14</b> (2): 3546–3554. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18385313" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/18385313">PMID 18385313</a><span class="printonly">. <a href="http://www.jneurosci.org/cgi/content/abstract/28/14/3546" class="external free" title="http://www.jneurosci.org/cgi/content/abstract/28/14/3546" rel="nofollow">http://www.jneurosci.org/cgi/content/abstract/28/14/3546</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Lasting+syndrome+of+depression+produced+by+reduction+in+serotonin+uptake+during+postnatal+development%3A+evidence+from+sleep%2C+stress%2C+and+behavior.&amp;rft.jtitle=J+Neurosci.&amp;rft.aulast=Popa+D%2C+L%C3%A9na+C%2C+Alexandre+C%2C+Adrien+J&amp;rft.au=Popa+D%2C+L%C3%A9na+C%2C+Alexandre+C%2C+Adrien+J&amp;rft.date=2008&amp;rft.volume=14&amp;rft.issue=2&amp;rft.pages=3546%E2%80%933554&amp;rft_id=info:pmid/18385313&amp;rft_id=http%3A%2F%2Fwww.jneurosci.org%2Fcgi%2Fcontent%2Fabstract%2F28%2F14%2F3546&amp;rfr_id=info:sid/en.wikipedia.org:Selective_serotonin_reuptake_inhibitor"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid16012532-50"><b><a href="#cite_ref-pmid16012532_50-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMaciag_D.2C_Simpson_KL.2C_Coppinger_D.2C_.27.27et_al.27.272006">Maciag D, Simpson KL, Coppinger D, <i>et al</i> (January 2006). "Neonatal antidepressant exposure has lasting effects on behavior and serotonin circuitry". <i>Neuropsychopharmacology</i> <b>31</b> (1): 47–57. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1038%2Fsj.npp.1300823" class="external text" title="http://dx.doi.org/10.1038%2Fsj.npp.1300823" rel="nofollow">10.1038/sj.npp.1300823</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16012532" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16012532">PMID 16012532</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Neonatal+antidepressant+exposure+has+lasting+effects+on+behavior+and+serotonin+circuitry&amp;rft.jtitle=Neuropsychopharmacology&amp;rft.aulast=Maciag+D%2C+Simpson+KL%2C+Coppinger+D%2C+%27%27et+al%27%27&amp;rft.au=Maciag+D%2C+Simpson+KL%2C+Coppinger+D%2C+%27%27et+al%27%27&amp;rft.date=January+2006&amp;rft.volume=31&amp;rft.issue=1&amp;rft.pages=47%E2%80%9357&amp;rft_id=info:doi/10.1038%2Fsj.npp.1300823&amp;rft_id=info:pmid/16012532&amp;rfr_id=info:sid/en.wikipedia.org:Selective_serotonin_reuptake_inhibitor"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid16483567-51"><b><a href="#cite_ref-pmid16483567_51-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMaciag_D.2C_Williams_L.2C_Coppinger_D.2C_Paul_IA2006">Maciag D, Williams L, Coppinger D, Paul IA (February 2006). "Neonatal citalopram exposure produces lasting changes in behavior which are reversed by adult imipramine treatment". <i>Eur. J. Pharmacol.</i> <b>532</b> (3): 265–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.ejphar.2005.12.081" class="external text" title="http://dx.doi.org/10.1016%2Fj.ejphar.2005.12.081" rel="nofollow">10.1016/j.ejphar.2005.12.081</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16483567" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16483567">PMID 16483567</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Neonatal+citalopram+exposure+produces+lasting+changes+in+behavior+which+are+reversed+by+adult+imipramine+treatment&amp;rft.jtitle=Eur.+J.+Pharmacol.&amp;rft.aulast=Maciag+D%2C+Williams+L%2C+Coppinger+D%2C+Paul+IA&amp;rft.au=Maciag+D%2C+Williams+L%2C+Coppinger+D%2C+Paul+IA&amp;rft.date=February+2006&amp;rft.volume=532&amp;rft.issue=3&amp;rft.pages=265%E2%80%939&amp;rft_id=info:doi/10.1016%2Fj.ejphar.2005.12.081&amp;rft_id=info:pmid/16483567&amp;rfr_id=info:sid/en.wikipedia.org:Selective_serotonin_reuptake_inhibitor"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-52"><b><a href="#cite_ref-52" title="">^</a></b> <a href="http://www.sciencemag.org/cgi/content/full/sci;306/5697/792" class="external text" title="http://www.sciencemag.org/cgi/content/full/sci;306/5697/792" rel="nofollow">NEUROSCIENCE: Prozac Treatment of Newborn Mice Raises Anxiety - Holden 306 (5697): 792 - Science</a></li>
<li id="cite_note-53"><b><a href="#cite_ref-53" title="">^</a></b> <a href="http://www.sciencemag.org/cgi/content/full/306/5697/879" class="external text" title="http://www.sciencemag.org/cgi/content/full/306/5697/879" rel="nofollow">Early-Life Blockade of the 5-HT Transporter Alters Emotional Behavior in Adult Mice - Ansorge et al. 306 (5697): 879 - Science</a></li>
<li id="cite_note-54"><b><a href="#cite_ref-54" title="">^</a></b> <a href="http://www.jneurosci.org/cgi/content/full/28/1/199" class="external text" title="http://www.jneurosci.org/cgi/content/full/28/1/199" rel="nofollow">Inhibition of Serotonin But Not Norepinephrine Transport during Development Produces Delayed, Persistent Perturbations of Emotional Behaviors in Mice - Ansorge et al. 28 (1): ...</a></li>
<li id="cite_note-pmid16741203-55"><b><a href="#cite_ref-pmid16741203_55-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMisri_S.2C_Reebye_P.2C_Kendrick_K.2C_Carter_D.2C_Ryan_D.2C_Grunau_RE.2C_Oberlander_TF2006">Misri S, Reebye P, Kendrick K, Carter D, Ryan D, Grunau RE, Oberlander TF (2006). "Internalizing behaviors in 4-year-old children exposed in utero to psychotropic medications.". <i>Am J Psychiatry</i> <b>163</b> (6): 1026–1032.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Internalizing+behaviors+in+4-year-old+children+exposed+in+utero+to+psychotropic+medications.&amp;rft.jtitle=Am+J+Psychiatry&amp;rft.aulast=Misri+S%2C+Reebye+P%2C+Kendrick+K%2C+Carter+D%2C+Ryan+D%2C+Grunau+RE%2C+Oberlander+TF&amp;rft.au=Misri+S%2C+Reebye+P%2C+Kendrick+K%2C+Carter+D%2C+Ryan+D%2C+Grunau+RE%2C+Oberlander+TF&amp;rft.date=2006&amp;rft.volume=163&amp;rft.issue=6&amp;rft.pages=1026%E2%80%931032&amp;rfr_id=info:sid/en.wikipedia.org:Selective_serotonin_reuptake_inhibitor"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-56"><b><a href="#cite_ref-56" title="">^</a></b> <a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;pubmedid=17101120" class="external text" title="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;pubmedid=17101120" rel="nofollow">Evidence that the deficit in sexual behavior in adult rats neonatally exposed to citalopram is a consequence of 5-HT1 receptor stimulation during development - Dorota Maciag, David Coppinger, and Ian A. Paul 1125(1): 171–175 - Brain Res.</a></li>
<li id="cite_note-57"><b><a href="#cite_ref-57" title="">^</a></b> <a href="http://www.fda.gov/CDER/DRUG/advisory/SSRI_PPHN200607.htm" class="external autonumber" title="http://www.fda.gov/CDER/DRUG/advisory/SSRI_PPHN200607.htm" rel="nofollow">[3]</a> FDA Public Health Advisory - Treatment Challenges of Depression in Pregnancy</li>
<li id="cite_note-ClinTox2004-isbister-58">^ <a href="#cite_ref-ClinTox2004-isbister_58-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-ClinTox2004-isbister_58-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-ClinTox2004-isbister_58-2" title=""><sup><i><b>c</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFIsbister_G.2C_Bowe_S.2C_Dawson_A.2C_Whyte_I2004">Isbister G, Bowe S, Dawson A, Whyte I (2004). "Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose". <i>J Toxicol Clin Toxicol</i> <b>42</b> (3): 277–85. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1081%2FCLT-120037428" class="external text" title="http://dx.doi.org/10.1081%2FCLT-120037428" rel="nofollow">10.1081/CLT-120037428</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15362595" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15362595">PMID 15362595</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Relative+toxicity+of+selective+serotonin+reuptake+inhibitors+%28SSRIs%29+in+overdose&amp;rft.jtitle=J+Toxicol+Clin+Toxicol&amp;rft.aulast=Isbister+G%2C+Bowe+S%2C+Dawson+A%2C+Whyte+I&amp;rft.au=Isbister+G%2C+Bowe+S%2C+Dawson+A%2C+Whyte+I&amp;rft.date=2004&amp;rft.volume=42&amp;rft.issue=3&amp;rft.pages=277%E2%80%9385&amp;rft_id=info:doi/10.1081%2FCLT-120037428&amp;rft_id=info:pmid/15362595&amp;rfr_id=info:sid/en.wikipedia.org:Selective_serotonin_reuptake_inhibitor"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-AmJEmergMed1992-Borys-59"><b><a href="#cite_ref-AmJEmergMed1992-Borys_59-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBorys_D.2C_Setzer_S.2C_Ling_L.2C_Reisdorf_J.2C_Day_L.2C_Krenzelok_E1992">Borys D, Setzer S, Ling L, Reisdorf J, Day L, Krenzelok E (1992). "Acute fluoxetine overdose: a report of 234 cases". <i>Am J Emerg Med</i> <b>10</b> (2): 115–20. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2F0735-6757%2892%2990041-U" class="external text" title="http://dx.doi.org/10.1016%2F0735-6757%2892%2990041-U" rel="nofollow">10.1016/0735-6757(92)90041-U</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/1586402" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/1586402">PMID 1586402</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Acute+fluoxetine+overdose%3A+a+report+of+234+cases&amp;rft.jtitle=Am+J+Emerg+Med&amp;rft.aulast=Borys+D%2C+Setzer+S%2C+Ling+L%2C+Reisdorf+J%2C+Day+L%2C+Krenzelok+E&amp;rft.au=Borys+D%2C+Setzer+S%2C+Ling+L%2C+Reisdorf+J%2C+Day+L%2C+Krenzelok+E&amp;rft.date=1992&amp;rft.volume=10&amp;rft.issue=2&amp;rft.pages=115%E2%80%9320&amp;rft_id=info:doi/10.1016%2F0735-6757%2892%2990041-U&amp;rft_id=info:pmid/1586402&amp;rfr_id=info:sid/en.wikipedia.org:Selective_serotonin_reuptake_inhibitor"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Lancet1996-Ostrom-60"><b><a href="#cite_ref-Lancet1996-Ostrom_60-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFOstr.C3.B6m_M.2C_Eriksson_A.2C_Thorson_J.2C_Spigset_O1996">Oström M, Eriksson A, Thorson J, Spigset O (1996). "Fatal overdose with citalopram". <i>Lancet</i> <b>348</b> (9023): 339–40. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0140-6736%2805%2964513-8" class="external text" title="http://dx.doi.org/10.1016%2FS0140-6736%2805%2964513-8" rel="nofollow">10.1016/S0140-6736(05)64513-8</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/8709713" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/8709713">PMID 8709713</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Fatal+overdose+with+citalopram&amp;rft.jtitle=Lancet&amp;rft.aulast=Ostr%C3%B6m+M%2C+Eriksson+A%2C+Thorson+J%2C+Spigset+O&amp;rft.au=Ostr%C3%B6m+M%2C+Eriksson+A%2C+Thorson+J%2C+Spigset+O&amp;rft.date=1996&amp;rft.volume=348&amp;rft.issue=9023&amp;rft.pages=339%E2%80%9340&amp;rft_id=info:doi/10.1016%2FS0140-6736%2805%2964513-8&amp;rft_id=info:pmid/8709713&amp;rfr_id=info:sid/en.wikipedia.org:Selective_serotonin_reuptake_inhibitor"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-DrugSaf1995-Sporer-61"><b><a href="#cite_ref-DrugSaf1995-Sporer_61-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFSporer_K1995">Sporer K (1995). "The serotonin syndrome. Implicated drugs, pathophysiology and management". <i>Drug Saf</i> <b>13</b> (2): 94–104. <a href="http://www.ncbi.nlm.nih.gov/pubmed/7576268" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/7576268">PMID 7576268</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+serotonin+syndrome.+Implicated+drugs%2C+pathophysiology+and+management&amp;rft.jtitle=Drug+Saf&amp;rft.aulast=Sporer+K&amp;rft.au=Sporer+K&amp;rft.date=1995&amp;rft.volume=13&amp;rft.issue=2&amp;rft.pages=94%E2%80%93104&amp;rft_id=info:pmid/7576268&amp;rfr_id=info:sid/en.wikipedia.org:Selective_serotonin_reuptake_inhibitor"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid15718537-62"><b><a href="#cite_ref-pmid15718537_62-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFGunnell_D.2C_Saperia_J.2C_Ashby_D2005">Gunnell D, Saperia J, Ashby D (2005). "Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review". <i>BMJ</i> <b>330</b> (7488): 385. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1136%2Fbmj.330.7488.385" class="external text" title="http://dx.doi.org/10.1136%2Fbmj.330.7488.385" rel="nofollow">10.1136/bmj.330.7488.385</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15718537" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15718537">PMID 15718537</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Selective+serotonin+reuptake+inhibitors+%28SSRIs%29+and+suicide+in+adults%3A+meta-analysis+of+drug+company+data+from+placebo+controlled%2C+randomised+controlled+trials+submitted+to+the+MHRA%27s+safety+review&amp;rft.jtitle=BMJ&amp;rft.aulast=Gunnell+D%2C+Saperia+J%2C+Ashby+D&amp;rft.au=Gunnell+D%2C+Saperia+J%2C+Ashby+D&amp;rft.date=2005&amp;rft.volume=330&amp;rft.issue=7488&amp;rft.pages=385&amp;rft_id=info:doi/10.1136%2Fbmj.330.7488.385&amp;rft_id=info:pmid/15718537&amp;rfr_id=info:sid/en.wikipedia.org:Selective_serotonin_reuptake_inhibitor"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-63"><b><a href="#cite_ref-63" title="">^</a></b> Lacasse JR, Leo J. <i><a href="http://medicine.plosjournals.org/archive/1549-1676/2/12/pdf/10.1371_journal.pmed.0020392-S.pdf" class="external text" title="http://medicine.plosjournals.org/archive/1549-1676/2/12/pdf/10.1371_journal.pmed.0020392-S.pdf" rel="nofollow">Serotonin and Depression: A Disconnect between the Advertisements and the Scientific Literature.</a></i> <a href="/wiki/PLoS_Medicine" title="PLoS Medicine">PLoS Medicine</a> 2005;2:e392.</li>
<li id="cite_note-64"><b><a href="#cite_ref-64" title="">^</a></b> Moncrieff J, Cohen D. <i><a href="http://medicine.plosjournals.org/archive/1549-1676/3/7/pdf/10.1371_journal.pmed.0030240-p-S.pdf" class="external text" title="http://medicine.plosjournals.org/archive/1549-1676/3/7/pdf/10.1371_journal.pmed.0030240-p-S.pdf" rel="nofollow">Do Antidepressants Cure or Create Abnormal Brain States?</a></i> PLoS Medicine 2006;3:e240.</li>
<li id="cite_note-65"><b><a href="#cite_ref-65" title="">^</a></b> Damsa C, Bumb A, Bianchi-Demicheli F, Vidailhet P, Sterck R, Andreoli A, Beyenburg S. "Dopamine-dependent" side effects of selective serotonin reuptake inhibitors: a clinical review". J Clin Psychiatry. 2004;65:1064-8. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15323590" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15323590">PMID 15323590</a>.</li>
<li id="cite_note-66"><b><a href="#cite_ref-66" title="">^</a></b> <a href="http://www.breggin.com/prbbooks.html" class="external text" title="http://www.breggin.com/prbbooks.html" rel="nofollow">Peter Breggin books including Toxic Psychiatry, Talking Back to Prozac, Brain-Disabling Treatments in Psychiatry</a></li>
<li id="cite_note-67"><b><a href="#cite_ref-67" title="">^</a></b> <cite style="font-style:normal" class="book" id="CITEREFValenstein1998">Valenstein, Elliot (1998). <i>Blaming the Brain: The Truth about Drugs and Mental Health</i>. The Free Press.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Blaming+the+Brain%3A+The+Truth+about+Drugs+and+Mental+Health&amp;rft.aulast=Valenstein&amp;rft.aufirst=Elliot&amp;rft.au=Valenstein%2C+Elliot&amp;rft.date=1998&amp;rft.pub=The+Free+Press&amp;rfr_id=info:sid/en.wikipedia.org:Selective_serotonin_reuptake_inhibitor"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-68"><b><a href="#cite_ref-68" title="">^</a></b> <cite style="font-style:normal" class="web" id="CITEREFKirsch_I.2C_Deacon_BJ.2C_Huedo-Medina_TB.2C_Scoboria_A.2C_Moore_TJ.2C_Johnson_BT2008">Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT (February 2008). <a href="http://medicine.plosjournals.org/perlserv/?request=get-document&amp;doi=10.1371/journal.pmed.0050045" class="external text" title="http://medicine.plosjournals.org/perlserv/?request=get-document&amp;doi=10.1371/journal.pmed.0050045" rel="nofollow">"Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration"</a> (htm). PLoS Medicine<span class="printonly">. <a href="http://medicine.plosjournals.org/perlserv/?request=get-document&amp;doi=10.1371/journal.pmed.0050045" class="external free" title="http://medicine.plosjournals.org/perlserv/?request=get-document&amp;doi=10.1371/journal.pmed.0050045" rel="nofollow">http://medicine.plosjournals.org/perlserv/?request=get-document&amp;doi=10.1371/journal.pmed.0050045</a></span><span class="reference-accessdate">. Retrieved on 2008-02-26</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Initial+Severity+and+Antidepressant+Benefits%3A+A+Meta-Analysis+of+Data+Submitted+to+the+Food+and+Drug+Administration&amp;rft.atitle=&amp;rft.aulast=Kirsch+I%2C+Deacon+BJ%2C+Huedo-Medina+TB%2C+Scoboria+A%2C+Moore+TJ%2C+Johnson+BT&amp;rft.au=Kirsch+I%2C+Deacon+BJ%2C+Huedo-Medina+TB%2C+Scoboria+A%2C+Moore+TJ%2C+Johnson+BT&amp;rft.date=February+2008&amp;rft.pub=PLoS+Medicine&amp;rft_id=http%3A%2F%2Fmedicine.plosjournals.org%2Fperlserv%2F%3Frequest%3Dget-document%26doi%3D10.1371%2Fjournal.pmed.0050045&amp;rfr_id=info:sid/en.wikipedia.org:Selective_serotonin_reuptake_inhibitor"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-69"><b><a href="#cite_ref-69" title="">^</a></b> <cite style="font-style:normal" class="news"><a href="http://www.guardian.co.uk/society/2008/feb/27/mentalhealth.health1" class="external text" title="http://www.guardian.co.uk/society/2008/feb/27/mentalhealth.health1" rel="nofollow">"The creation of the Prozac myth"</a>. The Guardian. February 27 2008<span class="printonly">. <a href="http://www.guardian.co.uk/society/2008/feb/27/mentalhealth.health1" class="external free" title="http://www.guardian.co.uk/society/2008/feb/27/mentalhealth.health1" rel="nofollow">http://www.guardian.co.uk/society/2008/feb/27/mentalhealth.health1</a></span><span class="reference-accessdate">. Retrieved on 2008-03-01</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=The+creation+of+the+Prozac+myth&amp;rft.atitle=&amp;rft.date=February+27+2008&amp;rft.pub=The+Guardian&amp;rft_id=http%3A%2F%2Fwww.guardian.co.uk%2Fsociety%2F2008%2Ffeb%2F27%2Fmentalhealth.health1&amp;rfr_id=info:sid/en.wikipedia.org:Selective_serotonin_reuptake_inhibitor"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-70"><b><a href="#cite_ref-70" title="">^</a></b> <cite style="font-style:normal" class="news" id="CITEREFDay2008">Day, Michael (26 February 2008). <a href="http://www.newscientist.com/article/dn13375-prozac-does-not-work-in-most-depressed-patients.html" class="external text" title="http://www.newscientist.com/article/dn13375-prozac-does-not-work-in-most-depressed-patients.html" rel="nofollow">"Prozac does not work in majority of depressed patients"</a>. New Scientist<span class="printonly">. <a href="http://www.newscientist.com/article/dn13375-prozac-does-not-work-in-most-depressed-patients.html" class="external free" title="http://www.newscientist.com/article/dn13375-prozac-does-not-work-in-most-depressed-patients.html" rel="nofollow">http://www.newscientist.com/article/dn13375-prozac-does-not-work-in-most-depressed-patients.html</a></span><span class="reference-accessdate">. Retrieved on 2008-03-01</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Prozac+does+not+work+in+majority+of+depressed+patients&amp;rft.atitle=&amp;rft.aulast=Day&amp;rft.aufirst=Michael&amp;rft.au=Day%2C+Michael&amp;rft.date=26+February+2008&amp;rft.pub=New+Scientist&amp;rft_id=http%3A%2F%2Fwww.newscientist.com%2Farticle%2Fdn13375-prozac-does-not-work-in-most-depressed-patients.html&amp;rfr_id=info:sid/en.wikipedia.org:Selective_serotonin_reuptake_inhibitor"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-71"><b><a href="#cite_ref-71" title="">^</a></b> <cite style="font-style:normal" class="news"><a href="http://www.nursingtimes.net/clinicalnews/2008/02/antidepressants_such_as_prozac_not_clinically_effective.html" class="external text" title="http://www.nursingtimes.net/clinicalnews/2008/02/antidepressants_such_as_prozac_not_clinically_effective.html" rel="nofollow">"Anti-depressants 'no better than placebo'"</a>. Nursing Times. 26 February 2008<span class="printonly">. <a href="http://www.nursingtimes.net/clinicalnews/2008/02/antidepressants_such_as_prozac_not_clinically_effective.html" class="external free" title="http://www.nursingtimes.net/clinicalnews/2008/02/antidepressants_such_as_prozac_not_clinically_effective.html" rel="nofollow">http://www.nursingtimes.net/clinicalnews/2008/02/antidepressants_such_as_prozac_not_clinically_effective.html</a></span><span class="reference-accessdate">. Retrieved on 2008-03-01</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Anti-depressants+%27no+better+than+placebo%27&amp;rft.atitle=&amp;rft.date=26+February+2008&amp;rft.pub=Nursing+Times&amp;rft_id=http%3A%2F%2Fwww.nursingtimes.net%2Fclinicalnews%2F2008%2F02%2Fantidepressants_such_as_prozac_not_clinically_effective.html&amp;rfr_id=info:sid/en.wikipedia.org:Selective_serotonin_reuptake_inhibitor"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-72"><b><a href="#cite_ref-72" title="">^</a></b> <cite style="font-style:normal" class="news" id="CITEREFBlue2008">Blue, Laura (February 26, 2008). <a href="http://www.time.com/time/health/article/0,8599,1717306,00.html" class="external text" title="http://www.time.com/time/health/article/0,8599,1717306,00.html" rel="nofollow">"Antidepressants Hardly Help"</a><span class="printonly">. <a href="http://www.time.com/time/health/article/0,8599,1717306,00.html" class="external free" title="http://www.time.com/time/health/article/0,8599,1717306,00.html" rel="nofollow">http://www.time.com/time/health/article/0,8599,1717306,00.html</a></span><span class="reference-accessdate">. Retrieved on 2008-03-01</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Antidepressants+Hardly+Help&amp;rft.atitle=&amp;rft.aulast=Blue&amp;rft.aufirst=Laura&amp;rft.au=Blue%2C+Laura&amp;rft.date=February+26%2C+2008&amp;rft_id=http%3A%2F%2Fwww.time.com%2Ftime%2Fhealth%2Farticle%2F0%2C8599%2C1717306%2C00.html&amp;rfr_id=info:sid/en.wikipedia.org:Selective_serotonin_reuptake_inhibitor"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-73"><b><a href="#cite_ref-73" title="">^</a></b> <a href="http://news.bbc.co.uk/2/hi/health/7263494.stm" class="external text" title="http://news.bbc.co.uk/2/hi/health/7263494.stm" rel="nofollow">Anti-depressants' 'little effect'</a> <a href="/wiki/BBC" title="BBC">BBC</a> News, February 26, 2008</li>
<li id="cite_note-pmid18199864-74"><b><a href="#cite_ref-pmid18199864_74-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFTurner_EH.2C_Matthews_AM.2C_Linardatos_E.2C_Tell_RA.2C_Rosenthal_R2008">Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R (January 2008). "<a href="http://content.nejm.org/cgi/content/full/358/3/252" class="external text" title="http://content.nejm.org/cgi/content/full/358/3/252" rel="nofollow">Selective publication of antidepressant trials and its influence on apparent efficacy</a>". <i>N. Engl. J. Med.</i> <b>358</b> (3): 252–60. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1056%2FNEJMsa065779" class="external text" title="http://dx.doi.org/10.1056%2FNEJMsa065779" rel="nofollow">10.1056/NEJMsa065779</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18199864" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/18199864">PMID 18199864</a><span class="printonly">. <a href="http://content.nejm.org/cgi/content/full/358/3/252" class="external free" title="http://content.nejm.org/cgi/content/full/358/3/252" rel="nofollow">http://content.nejm.org/cgi/content/full/358/3/252</a></span><span class="reference-accessdate">. Retrieved on 2008-05-29</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Selective+publication+of+antidepressant+trials+and+its+influence+on+apparent+efficacy&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.aulast=Turner+EH%2C+Matthews+AM%2C+Linardatos+E%2C+Tell+RA%2C+Rosenthal+R&amp;rft.au=Turner+EH%2C+Matthews+AM%2C+Linardatos+E%2C+Tell+RA%2C+Rosenthal+R&amp;rft.date=January+2008&amp;rft.volume=358&amp;rft.issue=3&amp;rft.pages=252%E2%80%9360&amp;rft_id=info:doi/10.1056%2FNEJMsa065779&amp;rft_id=info:pmid/18199864&amp;rft_id=http%3A%2F%2Fcontent.nejm.org%2Fcgi%2Fcontent%2Ffull%2F358%2F3%2F252&amp;rfr_id=info:sid/en.wikipedia.org:Selective_serotonin_reuptake_inhibitor"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-75"><b><a href="#cite_ref-75" title="">^</a></b> Center for Drug Evaluation and Research <i><a href="http://www.fda.gov/cder/drug/antidepressants" class="external text" title="http://www.fda.gov/cder/drug/antidepressants" rel="nofollow">Antidepressant Use in Children, Adolescents, and Adults</a></i>. Retrieved September 30, 2008.</li>
<li id="cite_note-76"><b><a href="#cite_ref-76" title="">^</a></b> <a href="http://www.cleveland.com/nation/index.ssf/2008/11/after_2_decade_decline_teen_su.html" class="external free" title="http://www.cleveland.com/nation/index.ssf/2008/11/after_2_decade_decline_teen_su.html" rel="nofollow">http://www.cleveland.com/nation/index.ssf/2008/11/after_2_decade_decline_teen_su.html</a></li>
<li id="cite_note-77"><b><a href="#cite_ref-77" title="">^</a></b> <a href="http://www.psychiatrictimes.com/display/article/10168/54606" class="external free" title="http://www.psychiatrictimes.com/display/article/10168/54606" rel="nofollow">http://www.psychiatrictimes.com/display/article/10168/54606</a></li>
</ol>
</div>
<p><a name="External_links" id="External_links"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Selective_serotonin_reuptake_inhibitor&amp;action=edit&amp;section=30" title="Edit section: External links">edit</a>]</span> <span class="mw-headline">External links</span></h2>
<ul>
<li><a href="http://www.fda.gov/cder/drug/antidepressants/PI_template.pdf" class="external text" title="http://www.fda.gov/cder/drug/antidepressants/PI_template.pdf" rel="nofollow">"black box" warning for SSRIs</a> at the <a href="/wiki/U.S._Food_and_Drug_Administration" title="U.S. Food and Drug Administration">U.S. Food and Drug Administration</a></li>
<li><a href="http://www.fda.gov/cder/drug/antidepressants/antidepressantList.htm" class="external text" title="http://www.fda.gov/cder/drug/antidepressants/antidepressantList.htm" rel="nofollow">FDA list of SSRIs</a> receiving the <a href="/wiki/Black_box_warning" title="Black box warning">black box warning</a> at FDA</li>
<li><a href="http://pi.lilly.com/us/prozac.pdf" class="external text" title="http://pi.lilly.com/us/prozac.pdf" rel="nofollow">PROZAC Product/Prescribing Information</a> at <a href="/wiki/Eli_Lilly_and_Company" title="Eli Lilly and Company">Eli Lilly and Company</a></li>
<li>Barry Yeoman <a href="http://www.barryyeoman.com/articles/courtroom.html" class="external text" title="http://www.barryyeoman.com/articles/courtroom.html" rel="nofollow">Putting Science in the Dock</a>, The Nation at barryyeoman.com</li>
<li><a href="/wiki/Medical_Subject_Headings" title="Medical Subject Headings">MeSH</a> <i><a href="http://www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?mode=&amp;term=Serotonin+uptake+inhibitors" class="external text" title="http://www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?mode=&amp;term=Serotonin+uptake+inhibitors" rel="nofollow">Serotonin+uptake+inhibitors</a></i></li>
</ul>
<table class="navbox" cellspacing="0" style=";">
<tr>
<td style="padding:2px;">
<table cellspacing="0" class="nowraplinks collapsible autocollapse" style="width:100%;background:transparent;color:inherit;;">
<tr>
<th style=";" colspan="2" class="navbox-title">
<div style="float:left; width:6em;text-align:left;">
<div class="noprint plainlinksneverexpand navbar" style="background:none; padding:0; font-weight:normal;;;border:none;; font-size:xx-small;"><a href="/wiki/Template:Antidepressants" title="Template:Antidepressants"><span title="View this template" style=";;border:none;">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="/wiki/Template_talk:Antidepressants" title="Template talk:Antidepressants"><span title="Discussion about this template" style=";;border:none;">d</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org/w/index.php?title=Template:Antidepressants&amp;action=edit" class="external text" title="http://en.wikipedia.org/w/index.php?title=Template:Antidepressants&amp;action=edit" rel="nofollow"><span title="Edit this template" style=";;border:none;;">e</span></a></div>
</div>
<span style="font-size:110%;"><a href="/wiki/Psychoanaleptic" title="Psychoanaleptic">Psychoanaleptics</a>: <a href="/wiki/Antidepressant" title="Antidepressant">antidepressants</a> (<a href="/wiki/ATC_code_N06#N06A_Antidepressants" title="ATC code N06">N06A</a>)</span></th>
</tr>
<tr style="height:2px;">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background: LightYellow;"><a href="/wiki/Monoamine_oxidase_inhibitor" title="Monoamine oxidase inhibitor">MAOIs</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><i>nonselective:</i> <i>non-reversible</i> (<a href="/wiki/Isocarboxazid" title="Isocarboxazid">Isocarboxazid</a>, <a href="/wiki/Iproclozide" title="Iproclozide">Iproclozide</a>, <a href="/wiki/Iproniazid" title="Iproniazid">Iproniazid</a>, <a href="/wiki/Nialamide" title="Nialamide">Nialamide</a>, <a href="/wiki/Phenelzine" title="Phenelzine">Phenelzine</a>, <a href="/wiki/Pheniprazine" title="Pheniprazine">Pheniprazine</a>) • <i>reversible</i> (<a href="/wiki/Tranylcypromine" title="Tranylcypromine">Tranylcypromine</a>)
<p><i><a href="/wiki/Monoamine_oxidase_A" title="Monoamine oxidase A">MAOA</a> (<a href="/wiki/Norepinephrine" title="Norepinephrine">N</a>/<a href="/wiki/Serotonin" title="Serotonin">S</a>):</i> <a href="/wiki/Clorgiline" title="Clorgiline">Clorgiline</a> • <a href="/wiki/Minaprine" title="Minaprine">Minaprine</a> • <i><a href="/wiki/Reversible_inhibitor_of_monoamine_oxidase_A" title="Reversible inhibitor of monoamine oxidase A">RIMAs</a></i> (<a href="/wiki/Befloxatone" title="Befloxatone">Befloxatone</a>, <a href="/wiki/Brofaromine" title="Brofaromine">Brofaromine</a>, <a href="/wiki/Cimoxatone" title="Cimoxatone">Cimoxatone</a>, <a href="/wiki/Harmaline" title="Harmaline">Harmaline</a>, <a href="/wiki/Moclobemide" title="Moclobemide">Moclobemide</a>, <a href="/wiki/Pirlindole" title="Pirlindole">Pirlindole</a>, <a href="/wiki/Toloxatone" title="Toloxatone">Toloxatone</a>)</p>
<i><a href="/wiki/Monoamine_oxidase_B" title="Monoamine oxidase B">MAOB</a> (<a href="/wiki/Dopamine" title="Dopamine">D</a>):</i> <a href="/wiki/Rasagiline" title="Rasagiline">Rasagiline</a> • <a href="/wiki/Selegiline" title="Selegiline">Selegiline</a> • <a href="/wiki/Pargyline" title="Pargyline">Pargyline</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background: LightYellow;"><a href="/wiki/Neurotransmitter_uptake_inhibitor" title="Neurotransmitter uptake inhibitor">RIs</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Serotonin_uptake_inhibitor" title="Serotonin uptake inhibitor">S RI</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><strong class="selflink">SS RI</strong> (<a href="/wiki/Alaproclate" title="Alaproclate">Alaproclate</a>, <a href="/wiki/Citalopram" title="Citalopram">Citalopram</a>, <a href="/wiki/Dapoxetine" title="Dapoxetine">Dapoxetine</a>, <a href="/wiki/Escitalopram" title="Escitalopram">Escitalopram</a>, <a href="/wiki/Femoxetine" title="Femoxetine">Femoxetine</a>, <a href="/wiki/Fluoxetine" title="Fluoxetine">Fluoxetine</a>, <a href="/wiki/Fluvoxamine" title="Fluvoxamine">Fluvoxamine</a>, <a href="/wiki/Paroxetine" title="Paroxetine">Paroxetine</a>, <a href="/wiki/Sertraline" title="Sertraline">Sertraline</a>, <a href="/wiki/Vilazodone" title="Vilazodone">Vilazodone</a>, <a href="/wiki/Zimelidine" title="Zimelidine">Zimelidine</a>)<br />
<i><a href="/wiki/Tricyclic_antidepressant" title="Tricyclic antidepressant">TCAs</a>/<a href="/wiki/Tetracyclic_antidepressant" title="Tetracyclic antidepressant">Tetras</a></i> (<a href="/wiki/Cianopramine" title="Cianopramine">Cianopramine</a>, <a href="/wiki/Clomipramine" title="Clomipramine">Clomipramine</a>, <a href="/wiki/Nefazodone" title="Nefazodone">Nefazodone</a>, <a href="/wiki/Trazodone" title="Trazodone">Trazodone</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Norepinephrine_reuptake_inhibitor" title="Norepinephrine reuptake inhibitor">N RI</a> / <a href="/wiki/Adrenergic_uptake_inhibitor" title="Adrenergic uptake inhibitor">A RI</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Atomoxetine" title="Atomoxetine">Atomoxetine</a> • <a href="/wiki/Ciclazindol" title="Ciclazindol">Ciclazindol</a> • <a href="/wiki/Maprotiline" title="Maprotiline">Maprotiline</a> • <a href="/wiki/Nisoxetine" title="Nisoxetine">Nisoxetine</a> • <a href="/wiki/Oxaprotiline" title="Oxaprotiline">Oxaprotiline</a> • <a href="/wiki/Reboxetine" title="Reboxetine">Reboxetine</a> • <a href="/wiki/Talopram" title="Talopram">Talopram</a> • <a href="/wiki/Viloxazine" title="Viloxazine">Viloxazine</a><br />
<i><a href="/wiki/Tricyclic_antidepressant" title="Tricyclic antidepressant">TCAs</a>/<a href="/wiki/Tetracyclic_antidepressant" title="Tetracyclic antidepressant">Tetras</a></i> (<a href="/wiki/Amoxapine" title="Amoxapine">Amoxapine</a>, <a href="/wiki/Butriptyline" title="Butriptyline">Butriptyline</a>, <a href="/wiki/Desipramine" title="Desipramine">Desipramine</a>/<a href="/wiki/Lofepramine" title="Lofepramine">Lofepramine</a>, <a href="/wiki/Dibenzepin" title="Dibenzepin">Dibenzepin</a>, <a href="/wiki/Dosulepin_hydrochloride" title="Dosulepin hydrochloride">Dosulepin</a>, <a href="/wiki/Doxepin" title="Doxepin">Doxepin</a>, <a href="/wiki/Imipramine" title="Imipramine">Imipramine</a>, <a href="/wiki/Iprindole" title="Iprindole">Iprindole</a>, <a href="/wiki/Melitracen" title="Melitracen">Melitracen</a>, <a href="/wiki/Nitroxazepine" title="Nitroxazepine">Nitroxazepine</a>, <a href="/wiki/Nortriptyline" title="Nortriptyline">Nortriptyline</a>, <a href="/wiki/Protriptyline" title="Protriptyline">Protriptyline</a>, <a href="/wiki/Trimipramine" title="Trimipramine">Trimipramine</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Dopamine_reuptake_inhibitor" title="Dopamine reuptake inhibitor">D RI</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Medifoxamine" title="Medifoxamine">Medifoxamine</a> • <a href="/wiki/Phenmetrazine" title="Phenmetrazine">Phenmetrazine</a> • <a href="/wiki/Vanoxerine" title="Vanoxerine">Vanoxerine</a><br />
<i><a href="/wiki/Tricyclic_antidepressant" title="Tricyclic antidepressant">TCAs</a></i> (<a href="/wiki/Amineptine" title="Amineptine">Amineptine</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Serotonin-norepinephrine_reuptake_inhibitor" title="Serotonin-norepinephrine reuptake inhibitor">SN RI</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Bicifadine" title="Bicifadine">Bicifadine</a> • <a href="/wiki/Clovoxamine" title="Clovoxamine">Clovoxamine</a> • <a href="/wiki/Desvenlafaxine" title="Desvenlafaxine">Desvenlafaxine</a> • <a href="/wiki/Duloxetine" title="Duloxetine">Duloxetine</a> • <a href="/wiki/Indeloxazine" title="Indeloxazine">Indeloxazine</a> • <a href="/wiki/Milnacipran" title="Milnacipran">Milnacipran</a> • <a href="/wiki/Nefazodone" title="Nefazodone">Nefazodone</a> • <a href="/wiki/Venlafaxine" title="Venlafaxine">Venlafaxine</a><br />
<i><a href="/wiki/Tricyclic_antidepressant" title="Tricyclic antidepressant">TCAs</a></i> (<a href="/wiki/Amitriptyline" title="Amitriptyline">Amitriptyline</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Norepinephrine-dopamine_reuptake_inhibitor" title="Norepinephrine-dopamine reuptake inhibitor">ND RI</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Bupropion" title="Bupropion">Bupropion</a> • <a href="/wiki/Nomifensine" title="Nomifensine">Nomifensine</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Serotonin-noradrenaline-dopamine_reuptake_inhibitor" title="Serotonin-noradrenaline-dopamine reuptake inhibitor">SND RI</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Brasofensine" title="Brasofensine">Brasofensine</a> • <a href="/wiki/Diclofensine" title="Diclofensine">Diclofensine</a> • <a href="/wiki/Tesofensine" title="Tesofensine">Tesofensine</a></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background: LightYellow;"><a href="/wiki/Selective_serotonin_reuptake_enhancer" title="Selective serotonin reuptake enhancer">SSREs</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><i><a href="/wiki/Tricyclic_antidepressant" title="Tricyclic antidepressant">TCAs</a></i> (<a href="/wiki/Tianeptine" title="Tianeptine">Tianeptine</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background: LightYellow;"><a href="/wiki/Adrenergic_antagonist" title="Adrenergic antagonist">AAs</a> at <a href="/wiki/Alpha-2_adrenergic_receptor" title="Alpha-2 adrenergic receptor">A2</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><i><a href="/wiki/Tetracyclic_antidepressant" title="Tetracyclic antidepressant">Tetras</a></i> (<a href="/wiki/Mianserin" title="Mianserin">Mianserin</a>, <a href="/wiki/Mirtazapine" title="Mirtazapine">Mirtazapine</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background: LightYellow;"><a href="/wiki/Sigma_receptor#Agonists" title="Sigma receptor">SAs</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><i><a href="/wiki/Tricyclic_antidepressant" title="Tricyclic antidepressant">TCAs</a></i> (<a href="/wiki/Opipramol" title="Opipramol">Opipramol</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background: LightYellow;"><a href="/wiki/Melatonin_receptor" title="Melatonin receptor">MAs</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><i><a href="/wiki/Melatonin_receptor#Agonists" title="Melatonin receptor">Melatonin receptor agonists</a></i> (<a href="/wiki/Agomelatine" title="Agomelatine">Agomelatine</a>)</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
<table class="navbox" cellspacing="0" style=";">
<tr>
<td style="padding:2px;">
<table cellspacing="0" class="nowraplinks collapsible autocollapse" style="width:100%;background:transparent;color:inherit;;">
<tr>
<th style=";" colspan="2" class="navbox-title">
<div style="float:left; width:6em;text-align:left;">
<div class="noprint plainlinksneverexpand navbar" style="background:none; padding:0; font-weight:normal;;;border:none;; font-size:xx-small;"><a href="/wiki/Template:Receptor_agonists_and_antagonists" title="Template:Receptor agonists and antagonists"><span title="View this template" style=";;border:none;">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="/wiki/Template_talk:Receptor_agonists_and_antagonists" title="Template talk:Receptor agonists and antagonists"><span title="Discussion about this template" style=";;border:none;">d</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org/w/index.php?title=Template:Receptor_agonists_and_antagonists&amp;action=edit" class="external text" title="http://en.wikipedia.org/w/index.php?title=Template:Receptor_agonists_and_antagonists&amp;action=edit" rel="nofollow"><span title="Edit this template" style=";;border:none;;">e</span></a></div>
</div>
<span style="font-size:110%;"><a href="/wiki/Receptor_(biochemistry)" title="Receptor (biochemistry)">Receptor</a> <a href="/wiki/Agonist" title="Agonist">agonists</a>, <a href="/wiki/Receptor_antagonist" title="Receptor antagonist">antagonists</a>, and <a href="/wiki/Neurotransmitter_uptake_inhibitor" title="Neurotransmitter uptake inhibitor">reuptake inhibitors</a></span></th>
</tr>
<tr style="height:2px;">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background-color: LightYellow;"><a href="/wiki/Biogenic_amine" title="Biogenic amine">BA</a>/<a href="/wiki/Monoamine_neurotransmitter" title="Monoamine neurotransmitter">M</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/5-HT_receptor" title="5-HT receptor">5-HT (serotonin) receptor</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Serotonin_receptor_agonist" title="Serotonin receptor agonist">Serotonin receptor agonist</a> (<a href="/wiki/5-HT4_agonist" title="5-HT4 agonist">5-HT<sub>4</sub></a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Serotonin_antagonist" title="Serotonin antagonist">Serotonin antagonist</a> (<a href="/wiki/5-HT3_antagonist" title="5-HT3 antagonist">5-HT<sub>3</sub></a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Serotonin_uptake_inhibitor" title="Serotonin uptake inhibitor">Serotonin uptake inhibitor</a> (<strong class="selflink">SSRI</strong>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Dopamine_receptor" title="Dopamine receptor">Dopamine receptor</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Dopamine_agonist" title="Dopamine agonist">Dopamine agonist</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Dopamine_antagonist" title="Dopamine antagonist">Dopamine antagonist</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Dopamine_reuptake_inhibitor" title="Dopamine reuptake inhibitor">Dopamine reuptake inhibitor</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Adrenergic_receptor" title="Adrenergic receptor">Adrenergic receptor</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Adrenergic_agonist" title="Adrenergic agonist">Adrenergic agonist</a> (<a href="/wiki/Alpha-adrenergic_agonist" title="Alpha-adrenergic agonist">Alpha</a>, <a href="/wiki/Beta-adrenergic_agonist" title="Beta-adrenergic agonist">Beta</a> <a href="/wiki/Beta1-adrenergic_agonist" title="Beta1-adrenergic agonist">1</a>/<a href="/wiki/Beta2-adrenergic_agonist" title="Beta2-adrenergic agonist">2</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Adrenergic_antagonist" title="Adrenergic antagonist">Adrenergic antagonist</a> (<a href="/wiki/Alpha_blocker" title="Alpha blocker">Alpha</a> <a href="/wiki/Alpha-1_blocker" title="Alpha-1 blocker">1</a>/<a href="/wiki/Alpha-2_blocker" title="Alpha-2 blocker">2</a>, <a href="/wiki/Beta_blocker" title="Beta blocker">Beta</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Adrenergic_uptake_inhibitor" title="Adrenergic uptake inhibitor">Adrenergic uptake inhibitor</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Histamine_receptor" title="Histamine receptor">Histamine receptor</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Histamine_agonist" title="Histamine agonist">Histamine agonist</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Histamine_antagonist" title="Histamine antagonist">Histamine antagonist</a> (<a href="/wiki/H1_antagonist" title="H1 antagonist">H<sub>1</sub></a>, <a href="/wiki/H2_antagonist" title="H2 antagonist">H<sub>2</sub></a>, <a href="/wiki/H3_antagonist" title="H3 antagonist">H<sub>3</sub></a>)</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background-color: LightYellow;"><a href="/wiki/Amino_acid" title="Amino acid">AA</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/GABA_receptor" title="GABA receptor">GABA receptor</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/GABA_agonist" title="GABA agonist">GABA agonist</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/GABA_antagonist" title="GABA antagonist">GABA antagonist</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Glutamate_receptor" title="Glutamate receptor">Glutamate receptor</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/NMDA_receptor" title="NMDA receptor">NMDA receptor</a> (<a href="/wiki/NMDA_receptor_antagonist" title="NMDA receptor antagonist">NMDA receptor antagonist</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/AMPA_receptor" title="AMPA receptor">AMPA receptor</a> (<a href="/wiki/Ampakine" title="Ampakine">Ampakine</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Excitatory_amino_acid_agonist" title="Excitatory amino acid agonist">Excitatory amino acid agonist</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Excitatory_amino_acid_antagonist" title="Excitatory amino acid antagonist">Excitatory amino acid antagonist</a></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background-color: LightYellow;"><a href="/wiki/Autonomic_nervous_system" title="Autonomic nervous system">ANS</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Acetylcholine_receptor" title="Acetylcholine receptor">Acetylcholine receptor</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Cholinergic" title="Cholinergic">Cholinergic</a> (<a href="/wiki/Muscarinic_agonist" title="Muscarinic agonist">Muscarinic</a>, <a href="/wiki/Nicotinic_agonist" title="Nicotinic agonist">Nicotinic</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Anticholinergic" title="Anticholinergic">Anticholinergic</a> (<a href="/wiki/Muscarinic_antagonist" title="Muscarinic antagonist">Muscarinic</a>, <a href="/wiki/Nicotinic_antagonist" title="Nicotinic antagonist">Nicotinic</a>/<a href="/wiki/Ganglionic_blocker" title="Ganglionic blocker">Ganglionic blocker</a>/<a href="/wiki/Neuromuscular-blocking_drugs" title="Neuromuscular-blocking drugs" class="mw-redirect">Neuromuscular-blocking drugs</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Acetylcholinesterase_inhibitor" title="Acetylcholinesterase inhibitor">Acetylcholinesterase inhibitor</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Adrenergic_receptor" title="Adrenergic receptor">Adrenergic receptor</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em">(SANS only—see above for details)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Parasympathetic_nervous_system" title="Parasympathetic nervous system">PANS</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Parasympathomimetic_drug" title="Parasympathomimetic drug">Parasympathomimetic</a> (<a href="/wiki/Cholinergic" title="Cholinergic">Cholinergic</a>, <a href="/wiki/Acetylcholinesterase_inhibitor" title="Acetylcholinesterase inhibitor">Acetylcholinesterase inhibitor</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Parasympatholytic" title="Parasympatholytic">Parasympatholytic</a> (<a href="/wiki/Anticholinergic" title="Anticholinergic">Anticholinergic</a>, <a href="/wiki/Ganglionic_blocker" title="Ganglionic blocker">Ganglionic blocker</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Sympathetic_nervous_system" title="Sympathetic nervous system">SANS</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Sympathomimetic_drug" title="Sympathomimetic drug">Sympathomimetic</a> (<a href="/wiki/Adrenergic_agonist" title="Adrenergic agonist">Adrenergic agonist</a>, <a href="/wiki/Monoamine_oxidase_inhibitor" title="Monoamine oxidase inhibitor">Monoamine oxidase inhibitor</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Sympatholytic" title="Sympatholytic">Sympatholytic</a> (<a href="/wiki/Adrenergic_antagonist" title="Adrenergic antagonist">Adrenergic antagonist</a>, <a href="/wiki/Alpha_blocker" title="Alpha blocker">Alpha blocker</a>, <a href="/wiki/Ganglionic_blocker" title="Ganglionic blocker">Ganglionic blocker</a>)</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background-color: LightYellow;">Other RAs</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Endothelin_receptor_antagonist" title="Endothelin receptor antagonist">Endothelin</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Angiotensin_II_receptor_antagonist" title="Angiotensin II receptor antagonist">Angiotensin II</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/NK1_receptor_antagonist" title="NK1 receptor antagonist">NK1</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Cannabinoid_receptor_antagonist" title="Cannabinoid receptor antagonist">Cannabinoid</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Vasopressin_receptor_antagonist" title="Vasopressin receptor antagonist">Vasopressin</a></div>
</td>
</tr>
</table>
</td>
</tr>
</table>


<!-- 
NewPP limit report
Preprocessor node count: 25552/1000000
Post-expand include size: 295758/2048000 bytes
Template argument size: 132574/2048000 bytes
Expensive parser function count: 7/500
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:29581-0!1!0!default!!en!2 and timestamp 20090404024251 -->
<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org/wiki/Selective_serotonin_reuptake_inhibitor">http://en.wikipedia.org/wiki/Selective_serotonin_reuptake_inhibitor</a>"</div>
			<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks"><a href="/wiki/Special:Categories" title="Special:Categories">Categories</a>:&#32;<span dir='ltr'><a href="/wiki/Category:Selective_serotonin_reuptake_inhibitors" title="Category:Selective serotonin reuptake inhibitors">Selective serotonin reuptake inhibitors</a></span></div><div id="mw-hidden-catlinks" class="mw-hidden-cats-hidden">Hidden categories:&#32;<span dir='ltr'><a href="/wiki/Category:All_articles_with_unsourced_statements" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></span> | <span dir='ltr'><a href="/wiki/Category:Articles_with_unsourced_statements_since_March_2009" title="Category:Articles with unsourced statements since March 2009">Articles with unsourced statements since March 2009</a></span> | <span dir='ltr'><a href="/wiki/Category:Articles_with_unsourced_statements_since_April_2008" title="Category:Articles with unsourced statements since April 2008">Articles with unsourced statements since April 2008</a></span> | <span dir='ltr'><a href="/wiki/Category:Articles_with_unsourced_statements_since_August_2007" title="Category:Articles with unsourced statements since August 2007">Articles with unsourced statements since August 2007</a></span> | <span dir='ltr'><a href="/wiki/Category:Articles_with_unsourced_statements_since_March_2008" title="Category:Articles with unsourced statements since March 2008">Articles with unsourced statements since March 2008</a></span> | <span dir='ltr'><a href="/wiki/Category:Articles_with_unsourced_statements_since_February_2008" title="Category:Articles with unsourced statements since February 2008">Articles with unsourced statements since February 2008</a></span></div></div>			<!-- end content -->
						<div class="visualClear"></div>
		</div>
	</div>
		</div>
		<div id="column-one">
	<div id="p-cactions" class="portlet">
		<h5>Views</h5>
		<div class="pBody">
			<ul>
	
				 <li id="ca-nstab-main" class="selected"><a href="/wiki/Selective_serotonin_reuptake_inhibitor" title="View the content page [c]" accesskey="c">Article</a></li>
				 <li id="ca-talk"><a href="/wiki/Talk:Selective_serotonin_reuptake_inhibitor" title="Discussion about the content page [t]" accesskey="t">Discussion</a></li>
				 <li id="ca-edit"><a href="/w/index.php?title=Selective_serotonin_reuptake_inhibitor&amp;action=edit" title="You can edit this page. &#10;Please use the preview button before saving. [e]" accesskey="e">Edit this page</a></li>
				 <li id="ca-history"><a href="/w/index.php?title=Selective_serotonin_reuptake_inhibitor&amp;action=history" title="Past versions of this page [h]" accesskey="h">History</a></li>			</ul>
		</div>
	</div>
	<div class="portlet" id="p-personal">
		<h5>Personal tools</h5>
		<div class="pBody">
			<ul>
				<li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Selective_serotonin_reuptake_inhibitor" title="You are encouraged to log in; however, it is not mandatory. [o]" accesskey="o">Log in / create account</a></li>
			</ul>
		</div>
	</div>
	<div class="portlet" id="p-logo">
		<a style="background-image: url(http://upload.wikimedia.org/wikipedia/en/b/bc/Wiki.png);" href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
	<div class='generated-sidebar portlet' id='p-navigation'>
		<h5>Navigation</h5>
		<div class='pBody'>
			<ul>
				<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li>
				<li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li>
				<li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content — the best of Wikipedia">Featured content</a></li>
				<li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li>
				<li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li>
			</ul>
		</div>
	</div>
	<div id="p-search" class="portlet">
		<h5><label for="searchInput">Search</label></h5>
		<div id="searchBody" class="pBody">
			<form action="/w/index.php" id="searchform"><div>
				<input type='hidden' name="title" value="Special:Search"/>
				<input id="searchInput" name="search" type="text" title="Search Wikipedia [f]" accesskey="f" value="" />
				<input type='submit' name="go" class="searchButton" id="searchGoButton"	value="Go" title="Go to a page with this exact name if one exists" />&nbsp;
				<input type='submit' name="fulltext" class="searchButton" id="mw-searchButton" value="Search" title="Search Wikipedia for this text" />
			</div></form>
		</div>
	</div>
	<div class='generated-sidebar portlet' id='p-interaction'>
		<h5>Interaction</h5>
		<div class='pBody'>
			<ul>
				<li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li>
				<li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li>
				<li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="The list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li>
				<li id="n-contact"><a href="/wiki/Wikipedia:Contact_us" title="How to contact Wikipedia">Contact Wikipedia</a></li>
				<li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Donate" title="Support us">Donate to Wikipedia</a></li>
				<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li>
			</ul>
		</div>
	</div>
	<div class="portlet" id="p-tb">
		<h5>Toolbox</h5>
		<div class="pBody">
			<ul>
				<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Selective_serotonin_reuptake_inhibitor" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li>
				<li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Selective_serotonin_reuptake_inhibitor" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li>
<li id="t-upload"><a href="/wiki/Wikipedia:Upload" title="Upload files [u]" accesskey="u">Upload file</a></li>
<li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</a></li>
				<li id="t-print"><a href="/w/index.php?title=Selective_serotonin_reuptake_inhibitor&amp;printable=yes" rel="alternate" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>				<li id="t-permalink"><a href="/w/index.php?title=Selective_serotonin_reuptake_inhibitor&amp;oldid=281579522" title="Permanent link to this version of the page">Permanent link</a></li><li id="t-cite"><a href="/w/index.php?title=Special:Cite&amp;page=Selective_serotonin_reuptake_inhibitor&amp;id=281579522">Cite this page</a></li>			</ul>
		</div>
	</div>
	<div id="p-lang" class="portlet">
		<h5>Languages</h5>
		<div class="pBody">
			<ul>
				<li class="interwiki-cs"><a href="http://cs.wikipedia.org/wiki/SSRI">Česky</a></li>
				<li class="interwiki-da"><a href="http://da.wikipedia.org/wiki/Lykkepille">Dansk</a></li>
				<li class="interwiki-de"><a href="http://de.wikipedia.org/wiki/Serotonin-Wiederaufnahmehemmer">Deutsch</a></li>
				<li class="interwiki-es"><a href="http://es.wikipedia.org/wiki/Inhibidor_selectivo_de_recaptaci%C3%B3n_de_Serotonina">Español</a></li>
				<li class="interwiki-fa"><a href="http://fa.wikipedia.org/wiki/%D9%85%D9%87%D8%A7%D8%B1%DA%A9%D9%86%D9%86%D8%AF%D9%87%E2%80%8C%D9%87%D8%A7%DB%8C_%D8%A8%D8%A7%D8%B2%D8%AC%D8%B0%D8%A8_%D8%B3%D8%B1%D9%88%D8%AA%D9%88%D9%86%DB%8C%D9%86">فارسی</a></li>
				<li class="interwiki-fr"><a href="http://fr.wikipedia.org/wiki/Inhibiteur_s%C3%A9lectif_de_la_recapture_de_la_s%C3%A9rotonine">Français</a></li>
				<li class="interwiki-ko"><a href="http://ko.wikipedia.org/wiki/%EC%84%A0%ED%83%9D%EC%A0%81_%EC%84%B8%EB%A1%9C%ED%86%A0%EB%8B%8C_%EC%9E%AC%ED%9D%A1%EC%88%98_%EC%96%B5%EC%A0%9C%EC%A0%9C">한국어</a></li>
				<li class="interwiki-it"><a href="http://it.wikipedia.org/wiki/SSRI">Italiano</a></li>
				<li class="interwiki-he"><a href="http://he.wikipedia.org/wiki/SRI">עברית</a></li>
				<li class="interwiki-lt"><a href="http://lt.wikipedia.org/wiki/SSRI">Lietuvių</a></li>
				<li class="interwiki-hu"><a href="http://hu.wikipedia.org/wiki/Szelekt%C3%ADv_szerotoninvisszav%C3%A9tel-g%C3%A1tl%C3%B3k">Magyar</a></li>
				<li class="interwiki-nl"><a href="http://nl.wikipedia.org/wiki/Selectieve_serotonine-heropnameremmer">Nederlands</a></li>
				<li class="interwiki-ja"><a href="http://ja.wikipedia.org/wiki/%E9%81%B8%E6%8A%9E%E7%9A%84%E3%82%BB%E3%83%AD%E3%83%88%E3%83%8B%E3%83%B3%E5%86%8D%E5%8F%96%E3%82%8A%E8%BE%BC%E3%81%BF%E9%98%BB%E5%AE%B3%E8%96%AC">日本語</a></li>
				<li class="interwiki-no"><a href="http://no.wikipedia.org/wiki/Selektiv_serotoninreopptakshemmer">‪Norsk (bokmål)‬</a></li>
				<li class="interwiki-pl"><a href="http://pl.wikipedia.org/wiki/Selektywne_inhibitory_zwrotnego_wychwytu_serotoniny">Polski</a></li>
				<li class="interwiki-pt"><a href="http://pt.wikipedia.org/wiki/Inibidor_selectivo_de_recapta%C3%A7%C3%A3o_de_serotonina">Português</a></li>
				<li class="interwiki-fi"><a href="http://fi.wikipedia.org/wiki/Selektiivinen_serotoniinin_takaisinoton_est%C3%A4j%C3%A4">Suomi</a></li>
				<li class="interwiki-sv"><a href="http://sv.wikipedia.org/wiki/Selektiva_serotonin%C3%A5terupptagsh%C3%A4mmare">Svenska</a></li>
				<li class="interwiki-tr"><a href="http://tr.wikipedia.org/wiki/Selektif_serotonin_gerial%C4%B1m_inhibit%C3%B6rleri">Türkçe</a></li>
				<li class="interwiki-zh"><a href="http://zh.wikipedia.org/wiki/%E9%80%89%E6%8B%A9%E6%80%A7%E8%A1%80%E6%B8%85%E5%86%8D%E5%90%B8%E6%94%B6%E6%8A%91%E5%88%B6%E5%89%82">中文</a></li>
			</ul>
		</div>
	</div>
		</div><!-- end of the left (by default at least) column -->
			<div class="visualClear"></div>
			<div id="footer">
				<div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="/skins-1.5/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>
				<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="/images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>
			<ul id="f-list">
					<li id="lastmod"> This page was last modified on 3 April 2009, at 21:44.</li>
					<li id="copyright">All text is available under the terms of the <a class='internal' href="http://en.wikipedia.org/wiki/Wikipedia:Text_of_the_GNU_Free_Documentation_License" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="http://en.wikipedia.org/wiki/Wikipedia:Copyrights" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc.</a>, a U.S. registered <a class='internal' href="http://en.wikipedia.org/wiki/501%28c%29#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="http://en.wikipedia.org/wiki/Non-profit_organization" title="Non-profit organization">nonprofit</a> <a href="http://en.wikipedia.org/wiki/Charitable_organization" title="Charitable organization">charity</a>.<br /></li>
					<li id="privacy"><a href="http://wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
					<li id="about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
					<li id="disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
			</ul>
		</div>
</div>

		<script type="text/javascript">if (window.runOnloadHook) runOnloadHook();</script>
<!-- Served by srv152 in 0.085 secs. --></body></html>
